<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Inhaled corticosteroids in children with persistent asthma: dose‐response effects on growth - Pruteanu, AI - 2014 | Cochrane Library</title> <meta content="Inhaled corticosteroids in children with persistent asthma: dose‐response effects on growth - Pruteanu, AI - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009878.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Inhaled corticosteroids in children with persistent asthma: dose‐response effects on growth - Pruteanu, AI - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009878.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009878.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Inhaled corticosteroids in children with persistent asthma: dose‐response effects on growth" name="citation_title"/> <meta content="Aniela I Pruteanu" name="citation_author"/> <meta content="University of Montreal" name="citation_author_institution"/> <meta content="Bhupendrasinh F Chauhan" name="citation_author"/> <meta content="Linjie Zhang" name="citation_author"/> <meta content="Federal University of Rio Grande" name="citation_author_institution"/> <meta content="Sílvio OM Prietsch" name="citation_author"/> <meta content="Federal University of Rio Grande" name="citation_author_institution"/> <meta content="Francine M Ducharme" name="citation_author"/> <meta content="francine.m.ducharme@umontreal.ca" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD009878.pub2" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/07/16" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009878.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009878.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009878.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Inhalation; Adrenal Cortex Hormones [*administration &amp; dosage, adverse effects]; Androstadienes [administration &amp; dosage, adverse effects]; Anti‐Asthmatic Agents [*administration &amp; dosage, adverse effects]; Asthma [*drug therapy]; Beclomethasone [administration &amp; dosage, adverse effects]; Budesonide [administration &amp; dosage, adverse effects]; Dose‐Response Relationship, Drug; Fluticasone; Growth [*drug effects]; Growth Disorders [*chemically induced]; Mometasone Furoate; Pregnadienediols [administration &amp; dosage, adverse effects]; Pregnenediones [administration &amp; dosage, adverse effects]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009878.pub2&amp;doi=10.1002/14651858.CD009878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="JmNqPX1V";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009878\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009878\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009878\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009878\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ms","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009878.pub2",title:"Inhaled corticosteroids in children with persistent asthma: dose\\u2010response effects on growth",firstPublishedDate:"Jul 16, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Airways Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=JmNqPX1V&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009878.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009878.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009878.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009878.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009878.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009878.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009878.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009878.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009878.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009878.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3808 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009878.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/full#CD009878-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/full#CD009878-sec-0085"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/full#CD009878-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/full#CD009878-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/full#CD009878-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/full#CD009878-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/full#CD009878-sec-0052"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/full#CD009878-sec-0079"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/appendices#CD009878-sec-0090"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/table_n/CD009878StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/table_n/CD009878StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Inhaled corticosteroids in children with persistent asthma: dose‐response effects on growth </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/information#CD009878-cr-0002">Aniela I Pruteanu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/information#CD009878-cr-0003">Bhupendrasinh F Chauhan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/information#CD009878-cr-0004">Linjie Zhang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/information#CD009878-cr-0005">Sílvio OM Prietsch</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009878.pub2/information#CD009878-cr-0006"><i class="icon corresponding-author fa fa-envelope"></i>Francine M Ducharme</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/information/en#CD009878-sec-0099">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 16 July 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009878.pub2">https://doi.org/10.1002/14651858.CD009878.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009878-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009878-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009878-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009878-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009878-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009878-abs-0001" lang="en"> <section id="CD009878-sec-0001"> <h3 class="title" id="CD009878-sec-0001">Background</h3> <p>Inhaled corticosteroids (ICS) are the first‐line treatment for children with persistent asthma. Their potential for growth suppression remains a matter of concern for parents and physicians. </p> </section> <section id="CD009878-sec-0002"> <h3 class="title" id="CD009878-sec-0002">Objectives</h3> <p>To assess whether increasing the dose of ICS is associated with slower linear growth, weight gain and skeletal maturation in children with asthma. </p> </section> <section id="CD009878-sec-0003"> <h3 class="title" id="CD009878-sec-0003">Search methods</h3> <p>We searched the Cochrane Airways Group Specialised Register of trials (CAGR) and the ClinicalTrials.gov website up to March 2014. </p> </section> <section id="CD009878-sec-0004"> <h3 class="title" id="CD009878-sec-0004">Selection criteria</h3> <p>Studies were eligible if they were parallel‐group randomised trials evaluating the impact of different doses of the same ICS using the same device in both groups for a minimum of three months in children one to 17 years of age with persistent asthma. </p> </section> <section id="CD009878-sec-0005"> <h3 class="title" id="CD009878-sec-0005">Data collection and analysis</h3> <p>Two review authors ascertained methodological quality independently using the Cochrane Risk of bias tool. The primary outcome was linear growth velocity. Secondary outcomes included change over time in growth velocity, height, weight, body mass index and skeletal maturation. </p> </section> <section id="CD009878-sec-0006"> <h3 class="title" id="CD009878-sec-0006">Main results</h3> <p>Among 22 eligible trials<b>,</b> 17 pairs of groups comparisons were derived from 10 trials (3394 children with mild to moderate asthma), measured growth and contributed data to the meta‐analysis. Trials used ICS (beclomethasone, budesonide, ciclesonide, fluticasone or mometasone) as monotherapy or as combination therapy with a long‐acting beta<sub>2</sub>‐agonist and generally compared low (50 to 100 μg) versus low to medium (200 μg) doses of hydrofluoroalkane (HFA)‐beclomethasone equivalent over 12 to 52 weeks. In the four comparisons reporting linear growth over 12 months, a significant group difference was observed, clearly indicating lower growth velocity in the higher ICS dose group of 5.74 cm/y compared with 5.94 cm/y on lower‐dose ICS (N = 728 school‐aged children; mean difference (MD)0.20 cm/y, 95% confidence interval (CI) 0.02 to 0.39; high‐quality evidence): No statistically significant heterogeneity was noted between trials contributing data. The ICS molecules (ciclesonide, fluticasone, mometasone) used in these four comparisons did not significantly influence the magnitude of effect (X<sup>2</sup> = 2.19 (2 df), P value 0.33). Subgroup analyses on age, baseline severity of airway obstruction, ICS dose and concomitant use of non‐steroidal antiasthmatic drugs were not performed because of similarity across trials or inadequate reporting. A statistically significant group difference was noted in unadjusted change in height from zero to three months (nine comparisons; N = 944 children; MD 0.15, 95% CI ‐0.28 to ‐0.02; moderate‐quality evidence) in favour of a higher ICS dose. No statistically significant group differences in change in height were observed at other time points, nor were such differences in weight, body mass index and skeletal maturation reported with low quality of evidence due to imprecision. </p> </section> <section id="CD009878-sec-0007"> <h3 class="title" id="CD009878-sec-0007">Authors' conclusions</h3> <p>In prepubescent school‐aged children with mild to moderate persistent asthma, a small but statistically significant group difference in growth velocity was observed between low doses of ICS and low to medium doses of HFA‐beclomethasone equivalent, favouring the use of low‐dose ICS. No apparent difference in the magnitude of effect was associated with three molecules reporting one‐year growth velocity, namely, mometasone, ciclesonide and fluticasone. In view of prevailing parents’ and physicians’ concerns about the growth suppressive effect of ICS, lack of or incomplete reporting of growth velocity in more than 86% (19/22) of eligible paediatric trials, including those using beclomethasone and budesonide, is a matter of concern. All future paediatric trials comparing different doses of ICS with or without placebo should systematically document growth. Findings support use of the minimal effective ICS dose in children with asthma. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009878-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009878-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009878-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD009878-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009878-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009878-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009878-abs-0005">Bahasa Malaysia</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009878-abs-0003" lang="en"> <h3>Does altering the dose of inhaled corticosteroids make a difference in growth among children with asthma? </h3> <p><b>Background</b> </p> <p>Asthma guidelines recommend inhaled corticosteroids (ICS) as the first choice of treatment for children with persistent asthma that is not well controlled when only a reliever inhaler is used to treat symptoms. Steroids work by reducing inflammation in the lungs and are known to control underlying symptoms of asthma. However, parents and physicians remain concerned about the potential negative effect of ICS on growth. </p> <p><b>Review question</b> </p> <p>Does altering the dose of inhaled corticosteroids make a difference in the growth of children with asthma? </p> <p><b>What evidence did we find?</b> </p> <p>We studied whether a difference could be seen in the growth of children with persistent asthma who were using different doses of the same ICS molecule and the same delivery device. We found 22 eligible trials, but only 10 of them measured growth or other measures of interest. Overall, 3394 children included in the review combined 17 group comparisons (i.e. 17 pairs of groups of children with mild to moderate asthma using a particular dose and type of steroid in 10 trials). Trials used different ICS molecules (beclomethasone, budesonide, ciclesonide, fluticasone or mometasone) either on their own or in combination with a long‐acting beta<sub>2</sub>‐agonist (a drug used to open up the airways) and generally compared low doses of corticosteroids (50 to 100 μg) with low to medium (200 μg) doses of corticosteroids (converted in μg HFA‐beclomethasone equivalent) over 12 to 52 weeks. </p> <p><b>Results</b> </p> <p>We found a small but statistically significant group difference in growth over 12 months between these different doses clearly favouring the lower dose of ICS. The type of corticosteroid among newer molecules (ciclesonide, fluticasone, mometasone) did not seem to influence the impact on growth over one year. Differences in corticosteroid doses did not seem to affect the change in height, the gain in weight, the gain in body mass index and the maturation of bones. </p> <p><b>Quality of the evidence</b> </p> <p>This review is based on a small number of trials that reported data and were conducted on children with mild to moderate asthma. Only 10 of 22 studies measured the few outcomes of interest for this review, and only four comparisons reported growth over 12 months. Our confidence in the quality of evidence is high for this outcome, however it is low to moderate for several other outcomes, depending on the number of trials reporting these outcomes. Moreover, a few outcomes were reported only by a single trial; as these findings have not been confirmed by other trials, we downgraded the evidence for these outcomes to low quality. An insufficient number of trials have compared the effect of a larger difference in dose, for example, between a high dose and a low dose of ICS and of other popular molecules such as budesonide and beclomethasone over a year or longer of treatment. </p> <p><b>Conclusions</b> </p> <p>We report an ICS dose–dependent reduction in growth velocity in prepubescent school‐aged children with mild to moderate persistent asthma. The choice of ICS molecule (mometasone, ciclesonide or fluticasone) was not found to affect the level of growth velocity response over a year. The effect of corticosteroids on growth was not consistently reported: among 22 eligible trials, only four comparisons reported the effects of corticosteroids on growth over one year. In view of parents' and clinicians' concerns, lack of or incomplete reporting of growth is a matter of concern given the importance of the topic. We recommend that growth be systematically reported in all trials involving children taking ICS for three months or longer. Until further data comparing low versus high ICS dose and trials of longer duration are available, we recommend that the minimal effective ICS dose be used in all children with asthma. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009878-sec-0085" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009878-sec-0085"></div> <h3 class="title" id="CD009878-sec-0086">Implications for practice</h3> <section id="CD009878-sec-0086"> <p>In prepubescent school‐aged children with mild to moderate persistent asthma, a very small but statistically significant difference in linear growth over 12 months was observed between groups using ICS, with a dose difference ≤ 150 μg HFA‐beclomethasone equivalent over 52 weeks. A group difference of 0.2 cm was observed, favouring higher growth velocity with the lower ICS dose of fluticasone, mometasone or ciclesonide. As ICS doses most often were in the low range or at the limit of low and medium doses (200 μg), data were insufficient to allow exploration of a potential dose‐response relationship between ICS for a difference greater than 150 μg. We are unable to comment on the possible effects on growth of different ICS molecules, although fluticasone, mometasone and ciclesonide at doses of 200 μg/d or less did not appear to explain any variation in the size of effect across the studies. In view of prevailing parents’ and physicians’ concerns about the growth‐suppressive effect of ICS, lack or inadequate reporting of growth measurements in more than 86% (19/22) of eligible paediatric trials is a matter of concern and should call for systematic reporting of growth in all ICS paediatric trials. Until more data on low versus moderate and higher ICS doses are available, we recommend that ICS should be used at the lowest effective dose with the safest ICS molecules, and that children's growth should be systematically monitored during any ICS treatment. </p> </section> <h3 class="title" id="CD009878-sec-0087">Implications for research</h3> <section id="CD009878-sec-0087"> <p>Long‐term (longer than one year) trials of high methodological quality with adequate documentation of linear growth velocity in children with asthma treated with ICS are needed to provide a fair comparison of the safety of different ICS dose options. Future trials should aim for the following design characteristics. </p> <p> <ul id="CD009878-list-0007"> <li> <p>Pragmatic effectiveness trials.</p> </li> <li> <p>Double‐blinding, adequate randomisation and complete reporting of withdrawals and dropouts with intention‐to‐treat analysis. </p> </li> <li> <p>Parallel‐group design.</p> </li> <li> <p>Complete reporting of continuous (denominators, mean change and mean standard deviation of change) and dichotomous (denominators and rate) data. </p> </li> <li> <p>Minimal intervention period of 12 to 24 weeks to assess medium‐term effects and, over several years, to assess the long‐term impact of different ICS doses. </p> </li> <li> <p>Measuring and reporting, at minimum, of linear growth velocity at different time points during the study. </p> </li> <li> <p>Measuring and reporting of the change in standard deviation score (SDS) in growth velocity, in absolute gain in height, in weight z‐score, in BMI and in skeletal maturation between the beginning and the end of treatment. </p> </li> <li> <p>Adequate reporting of the adherence rate and concomitant use of non‐steroidal antiasthmatic drugs. </p> </li> <li> <p>Additional studies evaluating the impact on growth of LABA (long‐acting beta‐agonist) as a concomitant drug in children with ICS. </p> </li> </ul> </p> <p>Given the paucity of paediatric trials reporting growth, growth measurements should be a requirement for all ICS drug trials whether funded by pharmaceutical companies or national granting agencies. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009878-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009878-sec-0022"></div> <div class="table" id="CD009878-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Inhaled corticosteroids dose‐response effect</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Inhaled corticosteroids dose‐response effect</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> children with persistent asthma<br/> <b>Settings:</b> outpatients<br/> <b>Intervention:</b> lower‐dose inhaled corticosteroids </p> <p><b>Control:</b> higher‐dose ICS </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control group (higher‐dose ICS)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Intervention group (lower‐dose ICS)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Growth velocity over 12 months (cm/y)</b> <br/> (higher is better) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean growth velocity was 5.74 cm/y (range, 5.6 to 5.88)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Corresponding growth velocity on lower‐dose ICS was 0.2 cm/y higher: mean 5.94 cm/y (95% CI 5.76 to 6.13) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.20</b> (0.02 to 0.39) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>728<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Skoner 2011 data analysed using LRS model were used</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in height over 3 months (cm)</b> </p> <p>(higher is better)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Unadjusted mean change in height over 3 months was 1.34 cm (range, 0.9 to 1.8 cm)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Corresponding unadjusted change in height on lower‐dose ICS was 0.15 cm lower: mean 1.19 cm (95% CI 1.06 to 1.32) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD ‐0.15</b> (‐0.28 to ‐0.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>944<br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data analysis was unadjusted for confounders</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in height over 12 months (cm)</b> <br/> (higher is better) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Unadjusted mean change in height over a year was 4.56 cm (range, 3.6 to 5.73 cm)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Corresponding unadjusted change in height on lower‐dose ICS was 0.25 cm higher; mean 4.81 cm (95% CI 4.52 to 5.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.25</b> (‐0.04 to 0.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>548<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data analysis was unadjusted for confounders</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in SD scores over 12 months (height)</b> </p> <p>(low change is better)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Unadjusted mean change in SD score was ‐0.18 (range, ‐0.01 to ‐0.27)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Corresponding mean unadjusted change on lower‐dose ICS was 0.08 less; mean ‐0.10 (95% CI ‐0.21 to 0.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.08</b> (‐0.03 to 0.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>328<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data analysis was unadjusted for confounders</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in weight over 12 months (kg)</b> <br/> (higher is better) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean change in weight was 3.4 kg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Corresponding mean change in weight on lower‐dose ICS was 0.3 kg lower: mean 3.1 (95% CI 2.58 to 3.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD</b> ‐0.30 (‐0.82 to 0.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>408<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Based on only 1 trial</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in BMI over 12 months (kg/m<sup>2</sup>)</b> <br/> (higher is better) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean change in BMI was 0.7 kg/m<sup>2</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Corresponding mean change in BMI on lower‐dose ICS was 0.2 kg/m<sup>2</sup> less: mean 0.5 (95% CI 0.21 to 0.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD</b> ‐0.20 (‐0.49 to 0.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>408<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Based on only 1 trial</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in skeletal maturation over 12 months (years)</b> </p> <p>(higher is better)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean change in skeletal maturation was 0.95 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Corresponding mean change in skeletal maturation on lower‐dose ICS was 0.18 years more; mean 1.13 (95% CI 0.97 to 1.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD</b> 0.18 (0.02 to 0.34) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>181<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Based on only 1 trial</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> was the weighted mean control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Data analysis was unadjusted for confounders. </p> <p><sup>2</sup>Based on only 1 trial. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009878-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009878-sec-0023"></div> <p>This protocol is the first of a series of three review protocols exploring the safety profile of inhaled corticosteroids (ICS) in terms of growth in children with persistent asthma. The present review explored the dose‐response effect of ICS on growth. The second review compares the long‐term effects of ICS on growth (<a href="./references#CD009878-bbs2-0138" title="ZhangL , AxelssonI , PrietschSOM . Inhaled corticosteroids in children with persistent asthma: effects on growth. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD009471] ">Zhang 2011</a>), and the third examines the effects of different drugs and delivery devices on growth. For more comprehensive background data and additional references, see <a href="./references#CD009878-bbs2-0138" title="ZhangL , AxelssonI , PrietschSOM . Inhaled corticosteroids in children with persistent asthma: effects on growth. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD009471] ">Zhang 2011</a>. </p> <section id="CD009878-sec-0024"> <h3 class="title" id="CD009878-sec-0024">Description of the condition</h3> <p>Asthma is defined as a chronic inflammatory disorder of the airways in which many cells and cellular elements play a role. The chronic inflammation is associated with airway hyperresponsiveness that leads to recurrent episodes of wheezing, breathlessness, chest tightness and coughing, particularly at night or in the early morning. These episodes are usually associated with widespread, but variable, airflow obstruction within the lung that is often reversible either spontaneously or with treatment (<a href="./references#CD009878-bbs2-0110" title="Global Initiative for Asthma(GINA) . From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2014. http://www.ginasthma.org/local/uploads/files/GINA_Report_2014.pdf2014. ">GINA 2014</a>). In developed countries, the prevalence of childhood asthma has markedly increased over the past few decades (<a href="./references#CD009878-bbs2-0113" title="ISAAC Steering Committee. Worldwide variations in the prevalence of asthma symptoms: the International Studyof Asthma and Allergies in Childhood (ISAAC). European Respiratory Journal1998;12:315‐35. ">ISAAC 1998</a>; <a href="./references#CD009878-bbs2-0118" title="MasoliM , FabianD , HoltS , BeasleyR . Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy2004;59(5):469‐78. ">Masoli 2004</a>; <a href="./references#CD009878-bbs2-0097" title="AsherMI . Recent perspectives on global epidemiology of asthma in childhood. Allergologia et Immunopathologia (Madrid)2010;38(2):83‐7. ">Asher 2010</a>); however, this increase has recently reached a plateau in some of these countries (<a href="./references#CD009878-bbs2-0115" title="LaiC , BeasleyR , CraneJ , FoliakiS , ShahJ , WeilandS . Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax2009;64(6):476‐83. ">Lai 2009</a>; <a href="./references#CD009878-bbs2-0097" title="AsherMI . Recent perspectives on global epidemiology of asthma in childhood. Allergologia et Immunopathologia (Madrid)2010;38(2):83‐7. ">Asher 2010</a>). In contrast, asthma prevalence is sharply increasing in developing countries (Africa, Central and South America, Asia and the Pacific region), probably as a result of rapid and ongoing urbanisation and westernisation (<a href="./references#CD009878-bbs2-0099" title="BramanSS . The global burden of asthma. Chest2006;130:4S‐12S. ">Braman 2006</a>; <a href="./references#CD009878-bbs2-0097" title="AsherMI . Recent perspectives on global epidemiology of asthma in childhood. Allergologia et Immunopathologia (Madrid)2010;38(2):83‐7. ">Asher 2010</a>). The global burden of childhood asthma is continuing to rise. </p> </section> <section id="CD009878-sec-0025"> <h3 class="title" id="CD009878-sec-0025">Description of the intervention</h3> <p>ICS are widely considered the first‐line treatment for persistent asthma, both in adults and in children (<a href="./references#CD009878-bbs2-0119" title="National Heart Lung and Blood Institute. Guidelines for the diagnosis and management of asthma (EPR‐3). http://www.nhlbi.nih.gov/guidelines/asthma/ (accessed 20 June 2011). ">NHLBI 2007</a>; <a href="./references#CD009878-bbs2-0101" title="British Thoracic Society and Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. A national clinical guideline. May 2008 (revised January 2012). http://www.google.co.uk/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=1&amp;cad=rja&amp;ved=0CDYQFjAA&amp;url=http%3A%2F%2Fwww.sign.ac.uk%2Fpdf%2Fsign101.pdf&amp;ei=qN_nUY3DPIem4gTc6IDoBQ&amp;usg=AFQjCNFZSipqqDue5MN9iBKrWV1MoM4gxg&amp;sig2=K4MXf4g8R4xKCs45kBiI‐g&amp;bvm=bv.49478099,d.bGE (accessed 20 June 2012). ">BTS 2012</a>; <a href="./references#CD009878-bbs2-0110" title="Global Initiative for Asthma(GINA) . From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2014. http://www.ginasthma.org/local/uploads/files/GINA_Report_2014.pdf2014. ">GINA 2014</a>; <a href="./references#CD009878-bbs2-0105" title="ChauhanBF , DucharmeFM . Anti‐leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database of Systematic Reviews2012, Issue 5. [DOI: 10.1002/14651858.CD002314.pub3] ">Chauhan 2012</a>; <a href="./references#CD009878-bbs2-0116" title="LougheedMD , LemiereC , DucharmeFM , LicskaiC , DelSD , RoweBH , et al. Canadian Thoracic Society 2012 guideline update. Diagnosis and management of asthma in preschoolers, children and adults. Canadian Respiratory Journal2012;19(2):127–64. ">Lougheed 2012</a>). Studies have demonstrated the clinical benefits of ICS in controlling asthma symptoms, reducing exacerbations and hospitalisations, decreasing airway hyperresponsiveness and airway inflammation, improving pulmonary function, improving quality of life and reducing asthma‐related deaths (<a href="./references#CD009878-bbs2-0114" title="JuniperEF , KlinePA , VanzieleghemMA , RamsdaleEH , O'ByrnePM , HargreaveFE . Effect of long‐term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid‐dependent asthmatics. American Review of Respiratory Disease1990;142(4):832‐6. ">Juniper 1990</a>; <a href="./references#CD009878-bbs2-0134" title="VanEssen‐ZandvlietEE , HughesMD , WaalkensHJ , DuivermanEJ , PocockSJ , KerrebijnKF . Effects of 22 months of treatment with inhaled corticosteroids and/or beta‐2‐agonists on lung function, airway responsiveness,and symptoms in children with asthma. American Review of Respiratory Disease1992;146(3):547‐54. ">Van Essen‐Zandvliet 1992</a>; <a href="./references#CD009878-bbs2-0121" title="OlivieriD , ChettaA , DelDonnoM , BertorelliG , CasaliniA , PesciA , et al. Effect of short‐term treatment with low‐dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo‐controlled study. American Journal of Respiratory and Critical Care Medicine1997;155(6):1864‐71. ">Olivieri 1997</a>; <a href="./references#CD009878-bbs2-0135" title="VanRensenEL , StraathofKC , Veselic‐CharvatMA , ZwindermanAH , BelEH , SterkPJ . Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma. Thorax1999;54(5):403‐8. ">Van Rensen 1999</a>; <a href="./references#CD009878-bbs2-0132" title="SuissaS , ErnstP , BenayounS , BaltzanM , CaiB . Low‐dose inhaled corticosteroids and the prevention of death from asthma. New England Journal of Medicine2000;343(5):332‐6. ">Suissa 2000</a>; <a href="./references#CD009878-bbs2-0106" title="CovarRA , SzeflerSJ , MartinRJ , SundstromDA , SilkoffPE , MurphyJ , et al. Relations between exhaled nitric oxide and measures of disease activity among children with mild‐to‐moderate asthma. Journal of Pediatrics2003;142(5):469‐75. ">Covar 2003</a>; <a href="./references#CD009878-bbs2-0089" title="AdamsNP , BestallJC , LassersonTJ , JonesP , CatesCJ . Fluticasone versus placebo for chronic asthma in adults and children. Cochrane Database of Systematic Reviews2008, Issue 4. [DOI: 10.1002/14651858.CD003135.pub4] ">Adams 2011a</a>; <a href="./references#CD009878-bbs2-0090" title="AdamsNP , BestallJB , MaloufR , LassersonTJ , JonesPW . Inhaled beclomethasone versus placebo for chronic asthma. Cochrane Database of Systematic Reviews2005, Issue 1. [DOI: 10.1002/14651858.CD002738.pub2] ">Adams 2011b</a>; <a href="./references#CD009878-bbs2-0091" title="AdamsNP , BestallJB , JonesPW . Budesonide versus placebo for chronic asthma in children and adults. Cochrane Database of Systematic Reviews1999, Issue 4. [DOI: 10.1002/14651858.CD003274] ">Adams 2011c</a>). Seven ICS are currently available for clinical use worldwide: beclomethasone dipropionate, budesonide, fluticasone propionate, mometasone fumarate, ciclesonide, flunisolide and triamcinolone acetate. Each inhaled corticosteroid has different pharmacokinetic and pharmacodynamic properties and biologic characteristics; however, all ICS can achieve similar therapeutic benefits when given at equipotent doses (<a href="./references#CD009878-bbs2-0131" title="SobandePO , KercsmarCM . Inhaled corticosteroids in asthma management. Respiratory Care2008;53(5):625‐33. ">Sobande 2008</a>; <a href="./references#CD009878-bbs2-0101" title="British Thoracic Society and Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. A national clinical guideline. May 2008 (revised January 2012). http://www.google.co.uk/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=1&amp;cad=rja&amp;ved=0CDYQFjAA&amp;url=http%3A%2F%2Fwww.sign.ac.uk%2Fpdf%2Fsign101.pdf&amp;ei=qN_nUY3DPIem4gTc6IDoBQ&amp;usg=AFQjCNFZSipqqDue5MN9iBKrWV1MoM4gxg&amp;sig2=K4MXf4g8R4xKCs45kBiI‐g&amp;bvm=bv.49478099,d.bGE (accessed 20 June 2012). ">BTS 2012</a>; <a href="./references#CD009878-bbs2-0110" title="Global Initiative for Asthma(GINA) . From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2014. http://www.ginasthma.org/local/uploads/files/GINA_Report_2014.pdf2014. ">GINA 2014</a>; <a href="./references#CD009878-bbs2-0116" title="LougheedMD , LemiereC , DucharmeFM , LicskaiC , DelSD , RoweBH , et al. Canadian Thoracic Society 2012 guideline update. Diagnosis and management of asthma in preschoolers, children and adults. Canadian Respiratory Journal2012;19(2):127–64. ">Lougheed 2012</a>). </p> <p>The optimal doses of ICS for persistent childhood asthma remain unclear. The most recent asthma guidelines recommend initiating ICS at low or medium daily doses for children with mild to moderate persistent asthma; however, patients with more severe asthma and those with poor response to low to moderate doses of ICS may require higher doses (≥ 400 μg/d of hydrofluoroalkane (HFA)‐beclomethasone or equivalent) to achieve satisfactory control of asthma (<a href="./references#CD009878-bbs2-0119" title="National Heart Lung and Blood Institute. Guidelines for the diagnosis and management of asthma (EPR‐3). http://www.nhlbi.nih.gov/guidelines/asthma/ (accessed 20 June 2011). ">NHLBI 2007</a>; <a href="./references#CD009878-bbs2-0101" title="British Thoracic Society and Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. A national clinical guideline. May 2008 (revised January 2012). http://www.google.co.uk/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=1&amp;cad=rja&amp;ved=0CDYQFjAA&amp;url=http%3A%2F%2Fwww.sign.ac.uk%2Fpdf%2Fsign101.pdf&amp;ei=qN_nUY3DPIem4gTc6IDoBQ&amp;usg=AFQjCNFZSipqqDue5MN9iBKrWV1MoM4gxg&amp;sig2=K4MXf4g8R4xKCs45kBiI‐g&amp;bvm=bv.49478099,d.bGE (accessed 20 June 2012). ">BTS 2012</a>; <a href="./references#CD009878-bbs2-0110" title="Global Initiative for Asthma(GINA) . From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2014. http://www.ginasthma.org/local/uploads/files/GINA_Report_2014.pdf2014. ">GINA 2014</a>; <a href="./references#CD009878-bbs2-0116" title="LougheedMD , LemiereC , DucharmeFM , LicskaiC , DelSD , RoweBH , et al. Canadian Thoracic Society 2012 guideline update. Diagnosis and management of asthma in preschoolers, children and adults. Canadian Respiratory Journal2012;19(2):127–64. ">Lougheed 2012</a>). </p> <p>Although ICS are generally considered safe treatment for children with asthma, the potential systemic adverse effects related to long‐term use of these drugs have been, and continue to be, a matter of concern, especially the effects on growth (<a href="./references#CD009878-bbs2-0122" title="PedersenS . Do inhaled corticosteroids inhibit growth in children?. Americian Journal of Respiratory and Critical Care Medicine2001;164(4):521‐35. ">Pedersen 2001</a>; <a href="./references#CD009878-bbs2-0095" title="AllenDB . Safety of inhaled corticosteroids in children. Pediatric Pulmonology2002;33:208‐20. ">Allen 2002</a>). In 1998, based on a report of the panel of experts, the US Food and Drug Administration (FDA) required labels on all ICS warning of a potential reduction in growth in children (<a href="./references#CD009878-bbs2-0109" title="USFood , Drug Administration(FDA) . FDA requires new pediatric labelling for inhaled, intranasal corticosteroids. FDA Talk Paper. November 9, 1998. ">FDA 1998</a>). Since that time, the relationship between ICS and growth impairment in children with asthma has been extensively debated in the literature and more so with the advent of new molecules with allegedly safer profiles (<a href="./references#CD009878-bbs2-0136" title="WitzmannKB , FinkRJ . Inhaled corticosteroids in childhood asthma: growing concerns. Drugs2000;59(Suppl 1):9‐14. ">Witzmann 2000</a>; <a href="./references#CD009878-bbs2-0100" title="BrandPLP . Inhaled corticosteroids reduce growth. Or do they?. European Respiratory Journal2001;17:287‐94. ">Brand 2001</a>; <a href="./references#CD009878-bbs2-0107" title="CreeseKH , DoullIJ . Effects of inhaled corticosteroids on growth in asthmatic children. Current Allergy and Asthma Reports2001;1(2):122‐6. ">Creese 2001</a>; <a href="./references#CD009878-bbs2-0137" title="WolthersO , HansenM , JuulA , NielsenHK , PedersenS . Knemometry, urine cortisol excretion and measures of the insulin‐like growth factor axis and collagen turnover in the assessment of systemic activity of inhaled corticosteroids in children with persistent asthma: effects on growth. Pediatric Research1997;41:44‐50. ">Wolthers 2001</a>; <a href="./references#CD009878-bbs2-0104" title="CarlsenKH , GerritsenJ . Inhaled steroids in children: adrenal suppression and growth impairment. European Respiratory Journal2002;19:985‐8. ">Carlsen 2002</a>; <a href="./references#CD009878-bbs2-0123" title="PriceJ , HindmarshP , HughesS , EfthimiouJ . Evaluating the effects of asthma therapy on childhood growth: what can be learnt from the published literature?. European Respiratory Journal2002;19:1179‐93. ">Price 2002a</a>; <a href="./references#CD009878-bbs2-0129" title="SinonenkoPC . Effects of inhaled or nasal glucocorticosteroids on adrenal function and growth. Journal of Pediatric Endocrinology and Metabolism2002;15(1):5‐26. ">Sizonenko 2002</a>; <a href="./references#CD009878-bbs2-0125" title="SalvatoniA , PiantanidaE , NosettiL , NespoliL . Inhaled corticosteroids in childhood asthma: long‐term effects on growth and adrenocortical function. Paediatric Drugs2003;5(6):351‐61. ">Salvatoni 2003</a>; <a href="./references#CD009878-bbs2-0096" title="AllenDB . Effects of inhaled steroids on growth, bone metabolism, and adrenal function. Advances in Pediatrics2006;53:101‐10. ">Allen 2006</a>). </p> </section> <section id="CD009878-sec-0026"> <h3 class="title" id="CD009878-sec-0026">How the intervention might work</h3> <p>ICS are the most potent anti‐inflammatory drugs available for long‐term treatment of persistent asthma. Possible molecular mechanisms for the anti‐inflammatory effects of ICS and for corticosteroid‐induced growth impairment have been reviewed previously (<a href="./references#CD009878-bbs2-0098" title="BarnesPJ , AdcockIM . How do corticosteroids work in asthma?. Annals of Internal Medicine2003;139:359‐70. ">Barnes 2003</a>; <a href="./references#CD009878-bbs2-0138" title="ZhangL , AxelssonI , PrietschSOM . Inhaled corticosteroids in children with persistent asthma: effects on growth. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD009471] ">Zhang 2011</a>). </p> </section> <section id="CD009878-sec-0027"> <h3 class="title" id="CD009878-sec-0027">Why it is important to do this review</h3> <p>One Cochrane systematic review (<a href="./references#CD009878-bbs2-0126" title="SharekPJ , BergmanD , FrancineD . Beclomethasone for asthma in children: effects on linear growth. Cochrane Database of Systematic Reviews2000, Issue 2. [DOI: 10.1002/14651858.CD001282] ">Sharek 2000a</a>) produced solid evidence supporting growth suppression estimated at 1.5 cm per year over seven to 12 months for 400 μg/d inhaled chlorofluorocarbon (CFC)‐propelled beclomethasone (equivalent to 200 μg/d of HFA‐propelled beclomethasone) in children with asthma. This review lately has been converted to a journal article (<a href="./references#CD009878-bbs2-0127" title="SharekPJ , BergmanDA . The effect of inhaled steroids on the linear growth of children with asthma: a meta‐analysis. Pediatrics2000;106:e8. ">Sharek 2000b</a>). However, it remains unclear whether corticosteroid‐induced growth retardation is dose dependent. We therefore decided to conduct this systematic review to evaluate the relationship between dose of ICS and risk of growth impairment in children with persistent asthma. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009878-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009878-sec-0028"></div> <p>To assess whether increasing the dose of ICS is associated with slower linear growth, weight gain and skeletal maturation in children with asthma. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009878-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009878-sec-0029"></div> <section id="CD009878-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009878-sec-0031"> <h4 class="title">Types of studies</h4> <p>Parallel‐group randomised controlled trials.</p> </section> <section id="CD009878-sec-0032"> <h4 class="title">Types of participants</h4> <p>Children one to 17 years of age with the diagnosis of persistent asthma.</p> </section> <section id="CD009878-sec-0033"> <h4 class="title">Types of interventions</h4> <p>Each treatment group should be given the same ICS at two or more different doses via the same delivery system for at least three months. ICS may be administered as monotherapy or in combination with other non‐steroidal asthma drugs (e.g. long‐acting beta‐agonists (LABAs), leukotriene receptor antagonists (LTRAs)). In all included trials, the intervention group depicted is the lower‐dose ICS and the control (comparison) group is the higher‐dose ICS. </p> </section> <section id="CD009878-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD009878-sec-0035"> <h5 class="title">Primary outcomes</h5> <p>Linear growth velocity (cm/y), obtained by measuring height at a number of time points during the study and performing linear regression of height over time (<a href="./references#CD009878-bbs2-0123" title="PriceJ , HindmarshP , HughesS , EfthimiouJ . Evaluating the effects of asthma therapy on childhood growth: what can be learnt from the published literature?. European Respiratory Journal2002;19:1179‐93. ">Price 2002a</a>). </p> </section> <section id="CD009878-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD009878-list-0001"> <li> <p>Change in growth velocity standard deviation (SD), defined as the difference between an individual's growth velocity and predicted growth velocity divided by the predicted growth velocity SD for individuals of the same age and sex (and ethnicity if available) (<a href="./references#CD009878-bbs2-0122" title="PedersenS . Do inhaled corticosteroids inhibit growth in children?. Americian Journal of Respiratory and Critical Care Medicine2001;164(4):521‐35. ">Pedersen 2001</a>). </p> </li> </ul> <ul id="CD009878-list-0002"> <li> <p>Change in absolute height (cm) over time.</p> </li> <li> <p>Change in weight (kg or z‐score) over time.</p> </li> <li> <p>Change in body mass index (added post hoc).</p> </li> <li> <p>Change in skeletal maturation (added post hoc).</p> </li> </ul> </p> <p>We did not intend to include lower leg length measured by knemometry as the outcome because this measurement correlates poorly with statural height and tends to overestimate potential effects of ICS on growth (<a href="./references#CD009878-bbs2-0108" title="EfthimiouJ , BarnesPJ . Effect of inhaled corticosteroids on bones and growth. European Respiratory Journal1998;11:1167‐77. ">Efthimiou 1998</a>; <a href="./references#CD009878-bbs2-0094" title="AllenDB . Limitations of short‐term studies in predicting long‐term adverse effects of inhaled corticosteroids. Allergy1999;54:29‐34. ">Allen 1999</a>). </p> </section> </section> </section> <section id="CD009878-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009878-sec-0038"> <h4 class="title">Electronic searches</h4> <p>We identified trials from the Cochrane Airways Group Specialised Register of Trials (CAGR), which were derived through systematic searches of bibliographic databases including the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, AMED and PsycINFO, and through handsearching of respiratory journals and meeting abstracts (see <a href="./appendices#CD009878-sec-0091">Appendix 1</a> for further details). All records in the CAGR coded as 'asthma' were searched using the following terms. </p> <p>(((steroid* or corticosteroid* or glucocorticoid* ) and inhal*) or budesonide or Pulmicort or fluticasone or Flixotide or Flovent or ciclesonide or Alvesco or triamcinolone or Kenalog or beclomethasone or beclometasone or Becotide or Becloforte or Becodisk or QVAR or Flunisolide or AeroBid or mometasone or Asmanex or Symbicort or Advair or Inuvair) AND (grow* or height* or SDS) AND (child* or paediat* or pediat* or adolesc* or teen* or prepubertal* or pre‐pubertal* or puberty or pubertal* or infan* or toddler* or bab* or young*) AND (dose* or dosage* or delivery* or administ* or response* or high* or low*) </p> <p>We also conducted a search of the ClinicalTrials.gov website. All databases were searched from their inception until March 2014 with no restriction on language of publication. </p> </section> <section id="CD009878-sec-0039"> <h4 class="title">Searching other resources</h4> <p>We checked the reference lists of all primary studies and review articles for additional references. We also searched manufacturers' clinical trial databases for potentially relevant unpublished studies, if needed. </p> </section> </section> <section id="CD009878-sec-0040"> <h3 class="title" id="CD009878-sec-0040">Data collection and analysis</h3> <section id="CD009878-sec-0041"> <h4 class="title">Selection of studies</h4> <p>Two review authors (AP and LZ or SP) independently assessed the titles and abstracts of all potential studies for inclusion identified by the search strategy. Full‐text articles were retrieved when they appeared to meet the inclusion criteria or when data in the title and abstract were insufficient to permit a clear decision regarding their inclusion. We resolved disagreements through discussion, or, if required, we consulted the third review author. </p> </section> <section id="CD009878-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (AP and BC) independently extracted data from the included trials using specially designed and pilot‐tested data extraction forms. For trials with multiple reports, we extracted data from each report separately and combined information across multiple data collection forms afterwards. We resolved disagreements by discussion and entered the extracted data into RevMan version 5.1 (<a href="./references#CD009878-bbs2-0124" title="Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration. Review Manager (RevMan) Version 5.0. Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration, 2008. ">Review Manager 5</a>). </p> <p>We extracted the following data.</p> <p> <ul id="CD009878-list-0003"> <li> <p>Study characteristics: year of publication, name of the first author, setting and source of funding/sponsorship. </p> </li> <li> <p>Methods: random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, completeness of outcome data, selective reporting and other sources of bias. </p> </li> <li> <p>Participants: sample size, demographics, inclusion and exclusion criteria.</p> </li> <li> <p>Intervention: type of ICS, dosage, frequency of administration, inhalation device, treatment duration and adherence to treatment, if available. </p> </li> <li> <p>Comparator: the same corticosteroid given at different dosage regimens (the same details as for intervention). </p> </li> <li> <p>Co‐interventions: type, dosage regimen and duration.</p> </li> <li> <p>Results: mean value of the outcome measures in each group, SD or other metrics for uncertainty (standard errors (SEs), confidence intervals (CIs), P values for differences in means) of outcome measurements in each group, number of participants who underwent randomisation, number of participants on whom outcomes were measured in each group. </p> </li> </ul> </p> </section> <section id="CD009878-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009878-bbs2-0112" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration. www.cochrane‐handbook.org, 2008. ">Higgins 2008</a>). Disagreements were resolved by discussion or by involving the third review author. We assessed the risk of bias according to the following domains. </p> <p> <ul id="CD009878-list-0004"> <li> <p>Allocation sequence generation.</p> </li> <li> <p>Concealment of allocation.</p> </li> <li> <p>Blinding of participants and investigators.</p> </li> <li> <p>Incomplete outcome data.</p> </li> <li> <p>Selective outcome reporting.</p> </li> <li> <p>Other risk of bias.</p> </li> </ul> </p> <p>We noted other sources of bias. We graded each potential source of bias as low, high or unclear risk. Studies were deemed to be of high methodological quality if information on randomisation generation, blinding and incomplete outcome data was available, indicating a low risk of bias. </p> </section> <section id="CD009878-sec-0044"> <h4 class="title">Measures of treatment effect</h4> <p>Measurements of growth were continuous outcomes, so we used mean difference (MD) and 95% CI as the metrics for treatment effects, as appropriate. </p> </section> <section id="CD009878-sec-0045"> <h4 class="title">Unit of analysis issues</h4> <p>We considered each individual comparison as the unit of analysis. We used analysed participants as sample size rather than the number of participants randomly assigned in the included studies. We had planned three pair‐wise comparisons of ICS doses in HFA‐beclomethasone or equivalent: low (≤ 200 μg) versus medium (201 to 400 μg) versus high dose (&gt; 400 μg) and low (≤ 200 μg) versus high (&gt; 400 μg) dose (<a href="./references#CD009878-bbs2-0116" title="LougheedMD , LemiereC , DucharmeFM , LicskaiC , DelSD , RoweBH , et al. Canadian Thoracic Society 2012 guideline update. Diagnosis and management of asthma in preschoolers, children and adults. Canadian Respiratory Journal2012;19(2):127–64. ">Lougheed 2012</a>). The ICS dose equivalence used for this review was based on Canadian Asthma Guidelines (<a href="./references#CD009878-bbs2-0116" title="LougheedMD , LemiereC , DucharmeFM , LicskaiC , DelSD , RoweBH , et al. Canadian Thoracic Society 2012 guideline update. Diagnosis and management of asthma in preschoolers, children and adults. Canadian Respiratory Journal2012;19(2):127–64. ">Lougheed 2012</a>), which are based on a combination of the dose equivalency mentioned in <a href="./references#CD009878-bbs2-0110" title="Global Initiative for Asthma(GINA) . From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2014. http://www.ginasthma.org/local/uploads/files/GINA_Report_2014.pdf2014. ">GINA 2014</a> and reported safety and efficacy data: 1 μg fluticasone = 1 μg mometasone = 1 μg ciclesonide = 1 μg of hydrofluoroalkane HFA‐beclomethasone = 2 μg budesonide = 2 μg CFC‐BDP = 4 μg flunisolide = 4 μg triamcinolone acetate. </p> </section> <section id="CD009878-sec-0046"> <h4 class="title">Dealing with missing data</h4> <p>We contacted investigators or study sponsors to verify key study characteristics and to obtain missing numerical outcome data when possible. </p> </section> <section id="CD009878-sec-0047"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used the I<sup>2</sup> statistic to measure heterogeneity among the trials in each analysis. In cases of substantial heterogeneity (I<sup>2</sup> &gt; 50%), we explored potential sources of heterogeneity by performing prespecified subgroup analysis and sensitivity analysis. We also conducted these analyses to explore the possibility of an effect modifier even if no significant heterogeneity was observed. </p> </section> <section id="CD009878-sec-0048"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to contact study authors to ask them to provide missing outcome data if we suspected reporting bias. When this was not possible, and when the missing data were thought to introduce serious bias, we planned to explore the impact of excluding such studies on the overall assessment of results by performing a sensitivity analysis<b>.</b> </p> </section> <section id="CD009878-sec-0049"> <h4 class="title">Data synthesis</h4> <p>We performed the meta‐analyses using the Cochrane statistical package RevMan 5 (<a href="./references#CD009878-bbs2-0124" title="Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration. Review Manager (RevMan) Version 5.0. Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration, 2008. ">Review Manager 5</a>). We used the fixed‐effect model unless statistical heterogeneity was found, in which case we used the random‐effects model. </p> </section> <section id="CD009878-sec-0050"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to carry out the following subgroup analyses for the primary outcome, measured at various points in time. </p> <p> <ul id="CD009878-list-0005"> <li> <p>Participant age: preschoolers (two to five years), prepubertal children (&gt; five to 12 years), adolescents (&gt; 12 to 18 years). </p> </li> <li> <p>Asthma severity: mild versus moderate versus severe.</p> </li> <li> <p>ICS molecule: beclomethasone, budesonide, fluticasone, mometasone, ciclesonide, flunisolide, triamcinolone. </p> </li> <li> <p>Concomitant use of non‐steroidal antiasthmatic drugs: ICS alone, ICS combined with non‐steroidal drugs, such as LABAs and LTRAs. </p> </li> <li> <p>Dose difference of ICS in HFA‐beclomethasone or equivalent (added as post hoc analysis).</p> </li> </ul> </p> </section> <section id="CD009878-sec-0051"> <h4 class="title">Sensitivity analysis</h4> <p>Sensitivity analysis was used to assess the potential impact of particular decisions or missing information on the findings of the review (<a href="./references#CD009878-bbs2-0112" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration. www.cochrane‐handbook.org, 2008. ">Higgins 2008</a>). We planned to carry out the following sensitivity analyses with regards to primary outcome by excluding from the analysis trials with the following. </p> <p> <ul id="CD009878-list-0006"> <li> <p>High risk of bias owing to missing data or unbinding, or both.</p> </li> <li> <p>Rate of adherence to ICS lower than 75% or lack of available data regarding adherence to treatment. </p> </li> <li> <p>Pharmaceutical industry sponsorship.</p> </li> </ul> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009878-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009878-sec-0052"></div> <section id="CD009878-sec-0053"> <h3 class="title">Description of studies</h3> <section id="CD009878-sec-0054"> <h4 class="title">Results of the search</h4> <p>The literature search conducted until March 2014 identified a total of 406 citations and abstracts (<a href="#CD009878-fig-0001">Figure 1</a>). Of these, 71 potential full texts were reviewed thoroughly for inclusion criteria. Twenty‐two trials, including 34 comparisons (<a href="./references#CD009878-sec-0105" title="">Characteristics of included studies</a>), were eligible for inclusion. Of these, 12 trials (17 comparisons) contributed no usable data to this review; four trials (five comparisons) either presented data in a different format than was specified in the protocol or reported incomplete data (<a href="./references#CD009878-bbs2-0012" title="JonassonG , CarlsenKH , JonassonC , MowinckelP . Low‐dose inhaled budesonide once or twice daily for 27 months in children with mild asthma. Allergy2000;55(8):740‐8. ">Jonasson 2000</a>; <a href="./references#CD009878-bbs2-0006" title="ChenA , ChenR ,  ZhongN . Systemic side effects of long‐term treatment with low dose inhaled corticosteroids in children with asthma. Chinese Journal of Tuberculosis and Respiratory Diseases2001;24(12):740‐3. ">Chen 2001</a>; <a href="./references#CD009878-bbs2-0030" title="TeperAM , ColomAJ , KofmanCD , MaffeyAF , VidaurretaSM , BergadaI . Effects of inhaled fluticasone propionate in children less than 2 years old with recurrent wheezing. Pediatric Pulmonology2004;37(2):111‐5. ">Teper 2004</a>; <a href="./references#CD009878-bbs2-0008" title="GelfandEW , GeorgitisJW , NoonanM , RuffME . Once‐daily ciclesonide in children: efficacy and safety in asthma. Journal of Pediatrics2006;148(3):377‐83. ">Gelfand 2006</a>; <a href="./references#CD009878-bbs2-0009" title="GelfandEW , GeorgitisJW , NoonanM , RuffME . Once‐daily ciclesonide in children: efficacy and safety in asthma. J Pediatrics2006;148(3):377‐83. ">Gelfand 2006 b</a>); seven trials (11 comparisons) did not measure children's growth as an outcome (<a href="./references#CD009878-bbs2-0011" title="JónassonG , CarlsenK‐H , BlomqvistP . Clinical efficacy of low‐dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids. European Respiratory Journal1998;12:1099‐104. ">Jonasson 1998</a>; <a href="./references#CD009878-bbs2-0010" title="GiorgiPL , OggianoN , KantarA , CoppaGV , RicciottiR , ArenaF , et al. Bone metabolism in children with asthma treated with nebulized flunisolide: a multicenter Italian study. Current Therapeutic Research, Clinical and Experimental1998;59(12):896‐908. ">Giorgi 1998</a>; <a href="./references#CD009878-bbs2-0018" title="PedenDB , BergerWE , NoonanMJ , ThomasMR , HendricksVL , HamedaniAG . Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. Journal of Allergy &amp; Clinical Immunology1998;102(1):32‐8. ">Peden 1998</a>; <a href="./references#CD009878-bbs2-0019" title="PedenDB , BergerWE , NoonanMJ , ThomasMR , HendricksVL , HamedaniAG . Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. Journal of Allergy &amp; Clinical Immunology1998;102(1):32‐8. ">Peden 1998 b</a>; <a href="./references#CD009878-bbs2-0002" title="BakerJ , MellonM , WaldJ , WelchM , Cruz‐RiveraM . A multiple‐dosing, placebo‐controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants. Pediatrics1999;103(2):414‐21. ">Baker 1999</a>; <a href="./references#CD009878-bbs2-0003" title="BakerJ , MellonM , WaldJ , WelchM , Cruz‐RiveraM . A multiple‐dosing, placebo‐controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants. Pediatrics1999;103(2):414‐421. ">Baker 1999 b</a>; <a href="./references#CD009878-bbs2-0013" title="KempJP , SkonerDP , SzeflerSJ , Walton‐BowenK , Cruz‐RiveraM , SmithJA . Once‐daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children. Annals of Allergy1999;83(3):231‐9. ">Kemp 1999</a>; <a href="./references#CD009878-bbs2-0014" title="KempJP , SkonerDP , SzeflerSJ , Walton‐BowenK , Cruz‐RiveraM . Once‐daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children. Annals of Allergy1999;83(3):231‐9. ">Kemp 1999 b</a>; <a href="./references#CD009878-bbs2-0007" title="DoniecZ , Pierzchala‐KoziecK , TomalakW , NowakD , KurzawaR . Powder budesonide decreases plasma level of native and cryptic met‐enkephalin in asthmatic children. International Review of Allergology and Clinical Immunology2004;10(3):105‐9. ">Doniec 2004</a>; <a href="./references#CD009878-bbs2-0015" title="KerwinEM , PearlmanDS , deGuiaT , CarlssonLG , GillenM , UryniakT , et al.  Evaluation of efficacy and safety of budesonide delivered via two dry powder inhalers. Current Medical Research and Opinion2008;24(5):1497‐510. ">Kerwin 2008</a>; <a href="./references#CD009878-bbs2-0016" title="KerwinEM , PearlmanDS , deGuiaT , CarlssonLG , GillenM , UryniakT . Evaluation of efficacy and safety of budesonide delivered via two dry powder inhalers. Current Medical Research and Opinion2008;24(5):1497‐510. ">Kerwin 2008 b</a>) and one trial was published as an abstract (<a href="./references#CD009878-bbs2-0017" title="LemanskeRF , LockeyRF , MurphyKR . Effects of one year of treatment with mometasone furoate metered dose inhaler (MF‐MDI) on growth in children with asthma. European Respiratory Journal2004;24(Suppl 48):379s. ">Lemanske 2004</a>). Consequently, 10 trials (17 comparisons) published as full text contributed at least one outcome to the meta‐analysis. </p> <div class="figure" id="CD009878-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Flow diagram of screening of trials." data-id="CD009878-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Flow diagram of screening of trials.</p> </div> </div> </div> </section> <section id="CD009878-sec-0055"> <h4 class="title">Included studies</h4> <p>Ten trials, reporting 17 comparisons (<a href="./references#CD009878-bbs2-0001" title="AllenDB , BronskyEA , LaForceCF , NathanRA , TinkelmanD , VandewalkerML , et al. Growth in asthmatic children treated with fluticasone propionate. Journal of Pediatrics1998;132(3 I):472‐7. ">Allen 1998</a>; <a href="./references#CD009878-bbs2-0022" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH , et al. Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. Journal of Pediatrics1998;132(6):976‐82. ">Shapiro 1998</a>; <a href="./references#CD009878-bbs2-0023" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 b</a>; <a href="./references#CD009878-bbs2-0024" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 c</a>; <a href="./references#CD009878-bbs2-0025" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 d</a>; <a href="./references#CD009878-bbs2-0032" title="VerberneAA , FrostC , DuivermanEJ , GrolMH , KerrebijnKF . Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. American Journal of Respiratory and Critical Care Medicine1998;158(1):213‐9. ">Verberne 1998</a>; <a href="./references#CD009878-bbs2-0033" title="VerberneAA , FrostC , DuivermanEJ , GrolMH , KerrebijnKF . Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. American Journal of Respiratory and Critical Care Medicine1998;158(1):213‐9. ">Verberne 1998 b</a>; <a href="./references#CD009878-bbs2-0034" title="WassermanRL , BakerJW , KimKT , BlakeKV , ScottCA , WuW , et al. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2‐ to 4‐year‐old patients with asthma: results of a double‐blind, placebo‐controlled study. Annals of Allergy, Asthma, and Immunology2006;96(6):808‐18. ">Wasserman 2006</a>; <a href="./references#CD009878-bbs2-0029" title="SorknessCA , LemanskeRFJr , MaugerDT , BoehmerSJ , ChinchilliVM , MartinezFD , et al. Long‐term comparison of 3 controller regimens for mild‐moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. Journal of Allergy and Clinical Immunology2007;119(1):64‐72. ">Sorkness 2007</a>; <a href="./references#CD009878-bbs2-0026" title="SkonerDP , MasperoJ , BanerjiD . Assessment of the long‐term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics2008;121(1):e1‐14. ">Skoner 2008</a>; <a href="./references#CD009878-bbs2-0020" title="PedersenS , PotterP , DachevS , BoshevaM , KaczmarekJ , SpringerE , et al. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the rainbow study. Respiratory Medicine2010;104(11):1618‐28. ">Pedersen 2010</a>; <a href="./references#CD009878-bbs2-0021" title="PedersenS , PotterP , DachevS , BoshevaM , KaczmarekJ , SpringerE , et al. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the rainbow study. Respiratory Medicine2010;104(11):1618‐28. ">Pedersen 2010 b</a>; <a href="./references#CD009878-bbs2-0031" title="Vaessen‐VerberneAA , van denBergNJ , vanNieropJC , BrackelHJ , GerritsGP , HopWC , et al. Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma. American Journal of Respiratory and Critical Care Medicine2010;182(10):1221‐7. ">Vaessen‐Verberne 2010</a>; <a href="./references#CD009878-bbs2-0004" title="BrandPL , Luz Garcia‐GarciaM , MorisonA , VermeulenJH , WeberHC . Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. Respiratory Medicine2011;105(11):1588‐95. ">Brand 2011</a>; <a href="./references#CD009878-bbs2-0005" title="BrandPL , Luz Garcia‐GarciaM , MorisonA , VermeulenJH , WeberHC . Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. Respiratory Medicine 2011/11;105(11):1588‐95. ">Brand 2011 b</a>; <a href="./references#CD009878-bbs2-0027" title="SkonerDP , MeltzerEO , MilgromHA , StryszakP , TeperA , StaudingerH . Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo‐controlled trial in children 4‐9 years old with mild persistent asthma. Journal of Asthma2011;48(8):848‐59. ">Skoner 2011</a>; <a href="./references#CD009878-bbs2-0028" title="SkonerDP , MeltzerEO , MilgromHA , StryszakP , TeperA , StaudingerH . Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo‐controlled trial in children 4‐9 years old with mild persistent asthma. Journal of Asthma2011;48(8):848‐59. ">Skoner 2011 b</a>) and enrolling 3394 children with confirmed persistent asthma, contributed data to the review. The following information pertains only to the 17 comparisons (from 10 included trials) contributing data to this review (<a href="./references#CD009878-sec-0105" title="">Characteristics of included studies</a>). The FDA has produced a guideline on evaluation of the effects of orally inhaled and intranasal corticosteroids, specific to placebo‐controlled trials in children (<a href="./references#CD009878-bbs2-0133" title="Guidance for industry orally inhaled and intranasal corticosteroids: evaluation of the effects on growth in children, 2007. http://www.fda.gov/cder/guidance/index.htm. ">US FDA 2007</a>); although some criteria were not relevant for dose‐response studies, we ascertained the compliance status to these guidelines of trials that contributed data to the meta‐analysis (<a href="#CD009878-tbl-0002">Table 1</a>; <a href="#CD009878-tbl-0003">Table 2</a>; <a href="#CD009878-tbl-0004">Table 3</a>). </p> <div class="table" id="CD009878-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">FDA study design</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Run‐in period ≥ 16 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Tx period ≥ 48 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Follow‐up period (to access catch‐up period)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Follow‐up period ≥ 8 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Recommended age (male: 3‐10.5 years; female: 3‐9.5 years, prepuberty (Tanner 1))</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mild asthma severity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No use of spacers</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo or active control group with no growth‐suppressing effect</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Allen 1998</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (2 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes<br/> (52 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Brand 2011</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (2‐4 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (24 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Partially (2‐6 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes (placebo or montelukast if control was insufficient)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pedersen 2010</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (2‐4 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (12 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes (6‐11 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Shapiro 1998</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> <p>(2 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (12 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No (6‐18 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Skoner 2008</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes<br/> (6 months) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes<br/> (52 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes<br/> (8 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes (5‐8 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Skoner 2011</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (1‐2 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes<br/> (52 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes<br/> (12 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sorkness 2007</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (2‐4 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes<br/> (48 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No (6‐14 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No (mild to moderate)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes (montelukast)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Vaessen‐Verberne 2010</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (6 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (26 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No (6‐16 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No (moderate)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Verbern 1998</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (6 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes<br/> (54 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No (6‐16 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes (salmeterol)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Wasserman 2006</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (2‐4 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (12 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Partially (24‐47 months)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>FDA = US Food and Drug Administration; NR = not reported.</p> <p>All studies were randomised, placebo‐controlled, double‐blind, parallel‐group trials.</p> </div> </div> <div class="table" id="CD009878-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">FDA statistical methods</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intention‐to‐treat analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Exclusion of pubescent children in analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Low and balanced withdrawals or missing data or patient dropouts</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Data presented as linear regression model but not change in height</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Baseline height, age, sex used as confounders in analysis model</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Catch‐up growth analysed with a linear regression model</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No nasal steroid during the study</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Allen 1998</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Brand 2011</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pedersen 2010</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No (dropout in placebo: 24% vs active treatment: 16%‐18%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Shapiro 1998</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Skoner 2008</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Skoner 2011</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sorkness 2007</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Vaessen‐Verberne 2010</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Verbern 1998</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Wasserman 2006</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009878-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">FDA possible sources of bias</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Use of stadiometer</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Height evaluation by same trained blinded examiner</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Height evaluation at the same time of the visit day</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Repeated (≥ 3) measurements during the study period</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Record of compliance</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Allen 1998</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Brand 2011</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pedersen 2010</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Shapiro 1998</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Skoner 2008</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Skoner 2011</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sorkness 2007</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Vaessen‐Verberne 2010</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Verbern 1998</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Wasserman 2006</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> </tbody> </table> </div> <section id="CD009878-sec-0056"> <h5 class="title">Design</h5> <p>All trials used a parallel‐group design.</p> </section> <section id="CD009878-sec-0057"> <h5 class="title">Participants</h5> <p>Three comparisons involved children two to five years of age (<a href="./references#CD009878-bbs2-0034" title="WassermanRL , BakerJW , KimKT , BlakeKV , ScottCA , WuW , et al. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2‐ to 4‐year‐old patients with asthma: results of a double‐blind, placebo‐controlled study. Annals of Allergy, Asthma, and Immunology2006;96(6):808‐18. ">Wasserman 2006</a>; <a href="./references#CD009878-bbs2-0004" title="BrandPL , Luz Garcia‐GarciaM , MorisonA , VermeulenJH , WeberHC . Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. Respiratory Medicine2011;105(11):1588‐95. ">Brand 2011</a>; <a href="./references#CD009878-bbs2-0005" title="BrandPL , Luz Garcia‐GarciaM , MorisonA , VermeulenJH , WeberHC . Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. Respiratory Medicine 2011/11;105(11):1588‐95. ">Brand 2011 b</a>), six comparisons involved prepubertal children, five to 12 years of age (<a href="./references#CD009878-bbs2-0001" title="AllenDB , BronskyEA , LaForceCF , NathanRA , TinkelmanD , VandewalkerML , et al. Growth in asthmatic children treated with fluticasone propionate. Journal of Pediatrics1998;132(3 I):472‐7. ">Allen 1998</a>; <a href="./references#CD009878-bbs2-0026" title="SkonerDP , MasperoJ , BanerjiD . Assessment of the long‐term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics2008;121(1):e1‐14. ">Skoner 2008</a>; <a href="./references#CD009878-bbs2-0020" title="PedersenS , PotterP , DachevS , BoshevaM , KaczmarekJ , SpringerE , et al. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the rainbow study. Respiratory Medicine2010;104(11):1618‐28. ">Pedersen 2010</a>; <a href="./references#CD009878-bbs2-0021" title="PedersenS , PotterP , DachevS , BoshevaM , KaczmarekJ , SpringerE , et al. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the rainbow study. Respiratory Medicine2010;104(11):1618‐28. ">Pedersen 2010 b</a>; <a href="./references#CD009878-bbs2-0027" title="SkonerDP , MeltzerEO , MilgromHA , StryszakP , TeperA , StaudingerH . Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo‐controlled trial in children 4‐9 years old with mild persistent asthma. Journal of Asthma2011;48(8):848‐59. ">Skoner 2011</a>; <a href="./references#CD009878-bbs2-0028" title="SkonerDP , MeltzerEO , MilgromHA , StryszakP , TeperA , StaudingerH . Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo‐controlled trial in children 4‐9 years old with mild persistent asthma. Journal of Asthma2011;48(8):848‐59. ">Skoner 2011 b</a>), and eight comparisons involved prepubertal and pubertal children (<a href="./references#CD009878-bbs2-0022" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH , et al. Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. Journal of Pediatrics1998;132(6):976‐82. ">Shapiro 1998</a>; <a href="./references#CD009878-bbs2-0023" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 b</a>; <a href="./references#CD009878-bbs2-0024" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 c</a>; <a href="./references#CD009878-bbs2-0025" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 d</a>; <a href="./references#CD009878-bbs2-0032" title="VerberneAA , FrostC , DuivermanEJ , GrolMH , KerrebijnKF . Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. American Journal of Respiratory and Critical Care Medicine1998;158(1):213‐9. ">Verberne 1998</a>; <a href="./references#CD009878-bbs2-0033" title="VerberneAA , FrostC , DuivermanEJ , GrolMH , KerrebijnKF . Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. American Journal of Respiratory and Critical Care Medicine1998;158(1):213‐9. ">Verberne 1998 b</a>; <a href="./references#CD009878-bbs2-0029" title="SorknessCA , LemanskeRFJr , MaugerDT , BoehmerSJ , ChinchilliVM , MartinezFD , et al. Long‐term comparison of 3 controller regimens for mild‐moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. Journal of Allergy and Clinical Immunology2007;119(1):64‐72. ">Sorkness 2007</a>; <a href="./references#CD009878-bbs2-0031" title="Vaessen‐VerberneAA , van denBergNJ , vanNieropJC , BrackelHJ , GerritsGP , HopWC , et al. Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma. American Journal of Respiratory and Critical Care Medicine2010;182(10):1221‐7. ">Vaessen‐Verberne 2010</a>). Most trials described a gender ratio hovering around 65% male participants. With regards to asthma severity, one comparison (<a href="./references#CD009878-bbs2-0026" title="SkonerDP , MasperoJ , BanerjiD . Assessment of the long‐term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics2008;121(1):e1‐14. ">Skoner 2008</a>) focused on asthmatic individuals with mild airway obstruction, two comparisons (<a href="./references#CD009878-bbs2-0032" title="VerberneAA , FrostC , DuivermanEJ , GrolMH , KerrebijnKF . Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. American Journal of Respiratory and Critical Care Medicine1998;158(1):213‐9. ">Verberne 1998</a>; <a href="./references#CD009878-bbs2-0033" title="VerberneAA , FrostC , DuivermanEJ , GrolMH , KerrebijnKF . Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. American Journal of Respiratory and Critical Care Medicine1998;158(1):213‐9. ">Verberne 1998 b</a>) focused on asthmatic individuals with mild to moderate airway obstruction, four comparisons (<a href="./references#CD009878-bbs2-0022" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH , et al. Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. Journal of Pediatrics1998;132(6):976‐82. ">Shapiro 1998</a>; <a href="./references#CD009878-bbs2-0023" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 b</a>; <a href="./references#CD009878-bbs2-0024" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 c</a>; <a href="./references#CD009878-bbs2-0025" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 d</a>) focused on asthmatic individuals with moderate to severe airway obstruction and the remaining six comparisons (<a href="./references#CD009878-bbs2-0001" title="AllenDB , BronskyEA , LaForceCF , NathanRA , TinkelmanD , VandewalkerML , et al. Growth in asthmatic children treated with fluticasone propionate. Journal of Pediatrics1998;132(3 I):472‐7. ">Allen 1998</a>; <a href="./references#CD009878-bbs2-0034" title="WassermanRL , BakerJW , KimKT , BlakeKV , ScottCA , WuW , et al. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2‐ to 4‐year‐old patients with asthma: results of a double‐blind, placebo‐controlled study. Annals of Allergy, Asthma, and Immunology2006;96(6):808‐18. ">Wasserman 2006</a>; <a href="./references#CD009878-bbs2-0020" title="PedersenS , PotterP , DachevS , BoshevaM , KaczmarekJ , SpringerE , et al. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the rainbow study. Respiratory Medicine2010;104(11):1618‐28. ">Pedersen 2010</a>; <a href="./references#CD009878-bbs2-0021" title="PedersenS , PotterP , DachevS , BoshevaM , KaczmarekJ , SpringerE , et al. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the rainbow study. Respiratory Medicine2010;104(11):1618‐28. ">Pedersen 2010 b</a>; <a href="./references#CD009878-bbs2-0027" title="SkonerDP , MeltzerEO , MilgromHA , StryszakP , TeperA , StaudingerH . Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo‐controlled trial in children 4‐9 years old with mild persistent asthma. Journal of Asthma2011;48(8):848‐59. ">Skoner 2011</a>; <a href="./references#CD009878-bbs2-0028" title="SkonerDP , MeltzerEO , MilgromHA , StryszakP , TeperA , StaudingerH . Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo‐controlled trial in children 4‐9 years old with mild persistent asthma. Journal of Asthma2011;48(8):848‐59. ">Skoner 2011 b</a>) failed to report the severity of baseline airway obstruction. Two comparisons (<a href="./references#CD009878-bbs2-0004" title="BrandPL , Luz Garcia‐GarciaM , MorisonA , VermeulenJH , WeberHC . Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. Respiratory Medicine2011;105(11):1588‐95. ">Brand 2011</a>; <a href="./references#CD009878-bbs2-0005" title="BrandPL , Luz Garcia‐GarciaM , MorisonA , VermeulenJH , WeberHC . Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. Respiratory Medicine 2011/11;105(11):1588‐95. ">Brand 2011 b</a>) pertained to preschool children with recurrent wheezing and a positive asthma predictive index or a positive screening test for atopy. Asthma triggers were seldom reported. </p> </section> <section id="CD009878-sec-0058"> <h5 class="title">Intervention duration</h5> <p>The duration of intervention varied from 12 weeks (seven comparisons; <a href="./references#CD009878-bbs2-0022" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH , et al. Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. Journal of Pediatrics1998;132(6):976‐82. ">Shapiro 1998</a>; <a href="./references#CD009878-bbs2-0023" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 b</a>; <a href="./references#CD009878-bbs2-0024" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 c</a>; <a href="./references#CD009878-bbs2-0025" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 d</a>; <a href="./references#CD009878-bbs2-0034" title="WassermanRL , BakerJW , KimKT , BlakeKV , ScottCA , WuW , et al. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2‐ to 4‐year‐old patients with asthma: results of a double‐blind, placebo‐controlled study. Annals of Allergy, Asthma, and Immunology2006;96(6):808‐18. ">Wasserman 2006</a>; <a href="./references#CD009878-bbs2-0020" title="PedersenS , PotterP , DachevS , BoshevaM , KaczmarekJ , SpringerE , et al. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the rainbow study. Respiratory Medicine2010;104(11):1618‐28. ">Pedersen 2010</a>; <a href="./references#CD009878-bbs2-0021" title="PedersenS , PotterP , DachevS , BoshevaM , KaczmarekJ , SpringerE , et al. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the rainbow study. Respiratory Medicine2010;104(11):1618‐28. ">Pedersen 2010 b</a>) to 24 weeks (two comparisons; <a href="./references#CD009878-bbs2-0004" title="BrandPL , Luz Garcia‐GarciaM , MorisonA , VermeulenJH , WeberHC . Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. Respiratory Medicine2011;105(11):1588‐95. ">Brand 2011</a>; <a href="./references#CD009878-bbs2-0005" title="BrandPL , Luz Garcia‐GarciaM , MorisonA , VermeulenJH , WeberHC . Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. Respiratory Medicine 2011/11;105(11):1588‐95. ">Brand 2011 b</a>) to 26 weeks (one comparison; <a href="./references#CD009878-bbs2-0031" title="Vaessen‐VerberneAA , van denBergNJ , vanNieropJC , BrackelHJ , GerritsGP , HopWC , et al. Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma. American Journal of Respiratory and Critical Care Medicine2010;182(10):1221‐7. ">Vaessen‐Verberne 2010</a>) to 52 weeks (seven comparisons; <a href="./references#CD009878-bbs2-0001" title="AllenDB , BronskyEA , LaForceCF , NathanRA , TinkelmanD , VandewalkerML , et al. Growth in asthmatic children treated with fluticasone propionate. Journal of Pediatrics1998;132(3 I):472‐7. ">Allen 1998</a>; <a href="./references#CD009878-bbs2-0032" title="VerberneAA , FrostC , DuivermanEJ , GrolMH , KerrebijnKF . Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. American Journal of Respiratory and Critical Care Medicine1998;158(1):213‐9. ">Verberne 1998</a>; <a href="./references#CD009878-bbs2-0033" title="VerberneAA , FrostC , DuivermanEJ , GrolMH , KerrebijnKF . Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. American Journal of Respiratory and Critical Care Medicine1998;158(1):213‐9. ">Verberne 1998 b</a>; <a href="./references#CD009878-bbs2-0029" title="SorknessCA , LemanskeRFJr , MaugerDT , BoehmerSJ , ChinchilliVM , MartinezFD , et al. Long‐term comparison of 3 controller regimens for mild‐moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. Journal of Allergy and Clinical Immunology2007;119(1):64‐72. ">Sorkness 2007</a>; <a href="./references#CD009878-bbs2-0026" title="SkonerDP , MasperoJ , BanerjiD . Assessment of the long‐term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics2008;121(1):e1‐14. ">Skoner 2008</a>; <a href="./references#CD009878-bbs2-0027" title="SkonerDP , MeltzerEO , MilgromHA , StryszakP , TeperA , StaudingerH . Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo‐controlled trial in children 4‐9 years old with mild persistent asthma. Journal of Asthma2011;48(8):848‐59. ">Skoner 2011</a>; <a href="./references#CD009878-bbs2-0028" title="SkonerDP , MeltzerEO , MilgromHA , StryszakP , TeperA , StaudingerH . Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo‐controlled trial in children 4‐9 years old with mild persistent asthma. Journal of Asthma2011;48(8):848‐59. ">Skoner 2011 b</a>). </p> </section> <section id="CD009878-sec-0059"> <h5 class="title">Intervention drugs</h5> <p>The ICS molecule used was beclomethasone dipropionate (BDP) (two comparisons; <a href="./references#CD009878-bbs2-0032" title="VerberneAA , FrostC , DuivermanEJ , GrolMH , KerrebijnKF . Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. American Journal of Respiratory and Critical Care Medicine1998;158(1):213‐9. ">Verberne 1998</a>; <a href="./references#CD009878-bbs2-0033" title="VerberneAA , FrostC , DuivermanEJ , GrolMH , KerrebijnKF . Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. American Journal of Respiratory and Critical Care Medicine1998;158(1):213‐9. ">Verberne 1998 b</a>), budesonide (BUD) (four comparisons; <a href="./references#CD009878-bbs2-0022" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH , et al. Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. Journal of Pediatrics1998;132(6):976‐82. ">Shapiro 1998</a>; <a href="./references#CD009878-bbs2-0023" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 b</a>; <a href="./references#CD009878-bbs2-0024" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 c</a>; <a href="./references#CD009878-bbs2-0025" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 d</a>), ciclesonide (CIC) (five comparisons; <a href="./references#CD009878-bbs2-0026" title="SkonerDP , MasperoJ , BanerjiD . Assessment of the long‐term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics2008;121(1):e1‐14. ">Skoner 2008</a>; <a href="./references#CD009878-bbs2-0020" title="PedersenS , PotterP , DachevS , BoshevaM , KaczmarekJ , SpringerE , et al. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the rainbow study. Respiratory Medicine2010;104(11):1618‐28. ">Pedersen 2010</a>; <a href="./references#CD009878-bbs2-0021" title="PedersenS , PotterP , DachevS , BoshevaM , KaczmarekJ , SpringerE , et al. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the rainbow study. Respiratory Medicine2010;104(11):1618‐28. ">Pedersen 2010 b</a>; <a href="./references#CD009878-bbs2-0004" title="BrandPL , Luz Garcia‐GarciaM , MorisonA , VermeulenJH , WeberHC . Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. Respiratory Medicine2011;105(11):1588‐95. ">Brand 2011</a>; <a href="./references#CD009878-bbs2-0005" title="BrandPL , Luz Garcia‐GarciaM , MorisonA , VermeulenJH , WeberHC . Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. Respiratory Medicine 2011/11;105(11):1588‐95. ">Brand 2011 b</a>), fluticasone propionate (FP) (four comparisons; <a href="./references#CD009878-bbs2-0001" title="AllenDB , BronskyEA , LaForceCF , NathanRA , TinkelmanD , VandewalkerML , et al. Growth in asthmatic children treated with fluticasone propionate. Journal of Pediatrics1998;132(3 I):472‐7. ">Allen 1998</a>; <a href="./references#CD009878-bbs2-0034" title="WassermanRL , BakerJW , KimKT , BlakeKV , ScottCA , WuW , et al. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2‐ to 4‐year‐old patients with asthma: results of a double‐blind, placebo‐controlled study. Annals of Allergy, Asthma, and Immunology2006;96(6):808‐18. ">Wasserman 2006</a>; <a href="./references#CD009878-bbs2-0029" title="SorknessCA , LemanskeRFJr , MaugerDT , BoehmerSJ , ChinchilliVM , MartinezFD , et al. Long‐term comparison of 3 controller regimens for mild‐moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. Journal of Allergy and Clinical Immunology2007;119(1):64‐72. ">Sorkness 2007</a>; <a href="./references#CD009878-bbs2-0031" title="Vaessen‐VerberneAA , van denBergNJ , vanNieropJC , BrackelHJ , GerritsGP , HopWC , et al. Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma. American Journal of Respiratory and Critical Care Medicine2010;182(10):1221‐7. ">Vaessen‐Verberne 2010</a>) or mometasone fumarate (MF) (two comparisons; <a href="./references#CD009878-bbs2-0027" title="SkonerDP , MeltzerEO , MilgromHA , StryszakP , TeperA , StaudingerH . Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo‐controlled trial in children 4‐9 years old with mild persistent asthma. Journal of Asthma2011;48(8):848‐59. ">Skoner 2011</a>; <a href="./references#CD009878-bbs2-0028" title="SkonerDP , MeltzerEO , MilgromHA , StryszakP , TeperA , StaudingerH . Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo‐controlled trial in children 4‐9 years old with mild persistent asthma. Journal of Asthma2011;48(8):848‐59. ">Skoner 2011 b</a>). The difference in the dose of ICS between two comparison groups (reported in HFA‐beclomethasone equivalent) varied by ≤ 150 μg in most trials. Most compared 100 μg (low dose) versus 200 μg (the cutoff limit between low and medium doses of ICS); in only four comparisons (<a href="./references#CD009878-bbs2-0023" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 b</a>; <a href="./references#CD009878-bbs2-0025" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 d</a>; <a href="./references#CD009878-bbs2-0032" title="VerberneAA , FrostC , DuivermanEJ , GrolMH , KerrebijnKF . Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. American Journal of Respiratory and Critical Care Medicine1998;158(1):213‐9. ">Verberne 1998</a>; <a href="./references#CD009878-bbs2-0031" title="Vaessen‐VerberneAA , van denBergNJ , vanNieropJC , BrackelHJ , GerritsGP , HopWC , et al. Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma. American Journal of Respiratory and Critical Care Medicine2010;182(10):1221‐7. ">Vaessen‐Verberne 2010</a> ) was the difference in the dose of ICS between groups ≥ 400 μg. Different devices were used, including aerochamber, diskhaler, dry powder inhaler, metered‐dose inhaler with or without spacer, nebuliser and turbohaler (further details are available in the <a href="./references#CD009878-sec-0105" title="">Characteristics of included studies</a> table). Yet all trials used the same inhalation device in within‐trial group comparisons. Adherence rate to ICS was reported by three of 10 trials; when reported, adherence was at or above 80%. All trials but one (<a href="./references#CD009878-bbs2-0029" title="SorknessCA , LemanskeRFJr , MaugerDT , BoehmerSJ , ChinchilliVM , MartinezFD , et al. Long‐term comparison of 3 controller regimens for mild‐moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. Journal of Allergy and Clinical Immunology2007;119(1):64‐72. ">Sorkness 2007</a>) were funded by the pharmaceutical industry. </p> </section> <section id="CD009878-sec-0060"> <h5 class="title">Co‐intervention</h5> <p>Three comparisons (<a href="./references#CD009878-bbs2-0032" title="VerberneAA , FrostC , DuivermanEJ , GrolMH , KerrebijnKF . Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. American Journal of Respiratory and Critical Care Medicine1998;158(1):213‐9. ">Verberne 1998</a>; <a href="./references#CD009878-bbs2-0020" title="PedersenS , PotterP , DachevS , BoshevaM , KaczmarekJ , SpringerE , et al. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the rainbow study. Respiratory Medicine2010;104(11):1618‐28. ">Pedersen 2010</a>; <a href="./references#CD009878-bbs2-0021" title="PedersenS , PotterP , DachevS , BoshevaM , KaczmarekJ , SpringerE , et al. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the rainbow study. Respiratory Medicine2010;104(11):1618‐28. ">Pedersen 2010 b</a>) enrolled only participants receiving ICS as monotherapy. Eleven comparisons (<a href="./references#CD009878-bbs2-0001" title="AllenDB , BronskyEA , LaForceCF , NathanRA , TinkelmanD , VandewalkerML , et al. Growth in asthmatic children treated with fluticasone propionate. Journal of Pediatrics1998;132(3 I):472‐7. ">Allen 1998</a>; <a href="./references#CD009878-bbs2-0022" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH , et al. Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. Journal of Pediatrics1998;132(6):976‐82. ">Shapiro 1998</a>; <a href="./references#CD009878-bbs2-0023" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 b</a>; <a href="./references#CD009878-bbs2-0024" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 c</a>; <a href="./references#CD009878-bbs2-0025" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 d</a>; <a href="./references#CD009878-bbs2-0034" title="WassermanRL , BakerJW , KimKT , BlakeKV , ScottCA , WuW , et al. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2‐ to 4‐year‐old patients with asthma: results of a double‐blind, placebo‐controlled study. Annals of Allergy, Asthma, and Immunology2006;96(6):808‐18. ">Wasserman 2006</a>; <a href="./references#CD009878-bbs2-0026" title="SkonerDP , MasperoJ , BanerjiD . Assessment of the long‐term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics2008;121(1):e1‐14. ">Skoner 2008</a>; <a href="./references#CD009878-bbs2-0004" title="BrandPL , Luz Garcia‐GarciaM , MorisonA , VermeulenJH , WeberHC . Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. Respiratory Medicine2011;105(11):1588‐95. ">Brand 2011</a>; <a href="./references#CD009878-bbs2-0005" title="BrandPL , Luz Garcia‐GarciaM , MorisonA , VermeulenJH , WeberHC . Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. Respiratory Medicine 2011/11;105(11):1588‐95. ">Brand 2011 b</a>; <a href="./references#CD009878-bbs2-0027" title="SkonerDP , MeltzerEO , MilgromHA , StryszakP , TeperA , StaudingerH . Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo‐controlled trial in children 4‐9 years old with mild persistent asthma. Journal of Asthma2011;48(8):848‐59. ">Skoner 2011</a>; <a href="./references#CD009878-bbs2-0028" title="SkonerDP , MeltzerEO , MilgromHA , StryszakP , TeperA , StaudingerH . Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo‐controlled trial in children 4‐9 years old with mild persistent asthma. Journal of Asthma2011;48(8):848‐59. ">Skoner 2011 b</a>) reported accepting participants who were using co‐interventions with additional antiasthmatic drugs such as LABAs, antileukotrienes or theophylline. Three comparisons (<a href="./references#CD009878-bbs2-0033" title="VerberneAA , FrostC , DuivermanEJ , GrolMH , KerrebijnKF . Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. American Journal of Respiratory and Critical Care Medicine1998;158(1):213‐9. ">Verberne 1998 b</a>; <a href="./references#CD009878-bbs2-0029" title="SorknessCA , LemanskeRFJr , MaugerDT , BoehmerSJ , ChinchilliVM , MartinezFD , et al. Long‐term comparison of 3 controller regimens for mild‐moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. Journal of Allergy and Clinical Immunology2007;119(1):64‐72. ">Sorkness 2007</a>; <a href="./references#CD009878-bbs2-0031" title="Vaessen‐VerberneAA , van denBergNJ , vanNieropJC , BrackelHJ , GerritsGP , HopWC , et al. Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma. American Journal of Respiratory and Critical Care Medicine2010;182(10):1221‐7. ">Vaessen‐Verberne 2010</a>) specifically compared ICS alone versus ICS + LABA, without other co‐interventions. </p> </section> <section id="CD009878-sec-0061"> <h5 class="title">Outcomes</h5> <p>The primary outcome was linear growth velocity (zero to 12 months), which was documented in four comparisons involving prepubescent children (<a href="./references#CD009878-bbs2-0001" title="AllenDB , BronskyEA , LaForceCF , NathanRA , TinkelmanD , VandewalkerML , et al. Growth in asthmatic children treated with fluticasone propionate. Journal of Pediatrics1998;132(3 I):472‐7. ">Allen 1998</a>; <a href="./references#CD009878-bbs2-0026" title="SkonerDP , MasperoJ , BanerjiD . Assessment of the long‐term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics2008;121(1):e1‐14. ">Skoner 2008</a>; <a href="./references#CD009878-bbs2-0027" title="SkonerDP , MeltzerEO , MilgromHA , StryszakP , TeperA , StaudingerH . Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo‐controlled trial in children 4‐9 years old with mild persistent asthma. Journal of Asthma2011;48(8):848‐59. ">Skoner 2011</a>; <a href="./references#CD009878-bbs2-0028" title="SkonerDP , MeltzerEO , MilgromHA , StryszakP , TeperA , StaudingerH . Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo‐controlled trial in children 4‐9 years old with mild persistent asthma. Journal of Asthma2011;48(8):848‐59. ">Skoner 2011 b</a>); in all cases, linear growth was analysed in three or more height measurements by regression analysis, with adjustment for co‐variates in all but one trial (<a href="./references#CD009878-bbs2-0001" title="AllenDB , BronskyEA , LaForceCF , NathanRA , TinkelmanD , VandewalkerML , et al. Growth in asthmatic children treated with fluticasone propionate. Journal of Pediatrics1998;132(3 I):472‐7. ">Allen 1998</a>). Secondary outcomes included change in height, growth velocity, weight, body mass index and skeletal maturation. </p> </section> </section> <section id="CD009878-sec-0062"> <h4 class="title">Excluded studies</h4> <p>Of 406 citations searched, 384 (94%) were excluded for the following exclusive reasons (<a href="#CD009878-fig-0001">Figure 1</a>): (1) duplicate references (N = 11), (2) not a randomised controlled trial (N = 76), (3) not a parallel‐group study (N = 84), (4) participants aged &lt; one year or ≥ 18 years (N = 33), (5) participants not asthmatic (or participants with asthma selected for another co‐morbidity, e.g. hypertension, diabetes) (N = 16), (6) participants with episodic asthma (N = 2), (7) acute and emergency care settings (N = 13), (8) no daily ICS stable dose in all participants in one of the comparison groups (N = 86), (9) not testing an additional ICS dose using the same molecule in all participants of the other comparison group (N = 50), (10) co‐interventions with oral corticosteroids (N = 3), and (11) treatment administered for less than 12 weeks (N = 10). Reasons for exclusion are provided in the <a href="./references#CD009878-sec-0106" title="">Characteristics of excluded studies</a>table. </p> </section> </section> <section id="CD009878-sec-0063"> <h3 class="title">Risk of bias in included studies</h3> <p>Details on risk of bias for each included trial are presented in the <a href="./references#CD009878-sec-0105" title="">Characteristics of included studies</a> tables. A graphical summary of risk of bias judgements is presented in <a href="#CD009878-fig-0002">Figure 2</a>. Although all trials were randomised, only 14 comparisons (41%) reported the method of randomisation. </p> <div class="figure" id="CD009878-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009878-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD009878-sec-0064"> <h4 class="title">Allocation</h4> <p>26 comparisons did not mention the method of concealment of treatment, and eight comparisons (23.5%) reported use of an appropriate concealment technique. </p> </section> <section id="CD009878-sec-0065"> <h4 class="title">Blinding</h4> <p>31 comparisons (90%) reported double‐blinding with convincing details, two comparisons (<a href="./references#CD009878-bbs2-0006" title="ChenA , ChenR ,  ZhongN . Systemic side effects of long‐term treatment with low dose inhaled corticosteroids in children with asthma. Chinese Journal of Tuberculosis and Respiratory Diseases2001;24(12):740‐3. ">Chen 2001</a>; <a href="./references#CD009878-bbs2-0007" title="DoniecZ , Pierzchala‐KoziecK , TomalakW , NowakD , KurzawaR . Powder budesonide decreases plasma level of native and cryptic met‐enkephalin in asthmatic children. International Review of Allergology and Clinical Immunology2004;10(3):105‐9. ">Doniec 2004</a>) did not report sufficient information to allow the review authors to ascertain blinding and one comparison (<a href="./references#CD009878-bbs2-0010" title="GiorgiPL , OggianoN , KantarA , CoppaGV , RicciottiR , ArenaF , et al. Bone metabolism in children with asthma treated with nebulized flunisolide: a multicenter Italian study. Current Therapeutic Research, Clinical and Experimental1998;59(12):896‐908. ">Giorgi 1998</a>) used an open‐label study design. </p> </section> <section id="CD009878-sec-0066"> <h4 class="title">Incomplete outcome data</h4> <p>31 comparisons (91%) reported all data with balanced numbers in both groups, and data from three comparisons (<a href="./references#CD009878-bbs2-0010" title="GiorgiPL , OggianoN , KantarA , CoppaGV , RicciottiR , ArenaF , et al. Bone metabolism in children with asthma treated with nebulized flunisolide: a multicenter Italian study. Current Therapeutic Research, Clinical and Experimental1998;59(12):896‐908. ">Giorgi 1998</a>; <a href="./references#CD009878-bbs2-0006" title="ChenA , ChenR ,  ZhongN . Systemic side effects of long‐term treatment with low dose inhaled corticosteroids in children with asthma. Chinese Journal of Tuberculosis and Respiratory Diseases2001;24(12):740‐3. ">Chen 2001</a>; <a href="./references#CD009878-bbs2-0017" title="LemanskeRF , LockeyRF , MurphyKR . Effects of one year of treatment with mometasone furoate metered dose inhaler (MF‐MDI) on growth in children with asthma. European Respiratory Journal2004;24(Suppl 48):379s. ">Lemanske 2004</a>) were unclear. All trials reported numbers of and reasons for withdrawals in both comparison groups. The proportion of overall withdrawals was variable between studies (10% to 30%), with a balance in withdrawal rates noted between groups given different ICS doses. </p> </section> <section id="CD009878-sec-0067"> <h4 class="title">Selective reporting</h4> <p>33 comparisons (97%) reported all outcomes mentioned in the methods section, with no apparent bias, and one comparison (<a href="./references#CD009878-bbs2-0006" title="ChenA , ChenR ,  ZhongN . Systemic side effects of long‐term treatment with low dose inhaled corticosteroids in children with asthma. Chinese Journal of Tuberculosis and Respiratory Diseases2001;24(12):740‐3. ">Chen 2001</a>) was unclear. </p> </section> <section id="CD009878-sec-0068"> <h4 class="title">Other potential sources of bias</h4> <p>In 31 comparisons, we encountered no other significant sources of bias, two comparisons (<a href="./references#CD009878-bbs2-0006" title="ChenA , ChenR ,  ZhongN . Systemic side effects of long‐term treatment with low dose inhaled corticosteroids in children with asthma. Chinese Journal of Tuberculosis and Respiratory Diseases2001;24(12):740‐3. ">Chen 2001</a>; <a href="./references#CD009878-bbs2-0007" title="DoniecZ , Pierzchala‐KoziecK , TomalakW , NowakD , KurzawaR . Powder budesonide decreases plasma level of native and cryptic met‐enkephalin in asthmatic children. International Review of Allergology and Clinical Immunology2004;10(3):105‐9. ">Doniec 2004</a>) were unclear and one comparison (<a href="./references#CD009878-bbs2-0010" title="GiorgiPL , OggianoN , KantarA , CoppaGV , RicciottiR , ArenaF , et al. Bone metabolism in children with asthma treated with nebulized flunisolide: a multicenter Italian study. Current Therapeutic Research, Clinical and Experimental1998;59(12):896‐908. ">Giorgi 1998</a>) was an open‐label study for which the primary outcome was not specified clearly. </p> <p>Except for three trials, all eligible trials contributing data were of high methodological quality. Two of four comparisons contributing to the primary outcome (<a href="./references#CD009878-bbs2-0001" title="AllenDB , BronskyEA , LaForceCF , NathanRA , TinkelmanD , VandewalkerML , et al. Growth in asthmatic children treated with fluticasone propionate. Journal of Pediatrics1998;132(3 I):472‐7. ">Allen 1998</a>; <a href="./references#CD009878-bbs2-0026" title="SkonerDP , MasperoJ , BanerjiD . Assessment of the long‐term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics2008;121(1):e1‐14. ">Skoner 2008</a>) were of high methodological quality. </p> </section> </section> <section id="CD009878-sec-0069"> <h3 class="title" id="CD009878-sec-0069">Effects of interventions</h3> <p>See: <a href="./full#CD009878-tbl-0001"><b>Summary of findings for the main comparison</b> Inhaled corticosteroids dose‐response effect</a> </p> <section id="CD009878-sec-0070"> <h4 class="title">Primary outcomes</h4> <section id="CD009878-sec-0071"> <h5 class="title">Linear growth velocity (cm/y)</h5> <p>A statistically significant group difference in linear growth (cm/y) over 12 months was noted between intervention (lower ICS dose) and control (higher ICS dose) groups (four comparisons; N = 728 children; MD 0.20 cm/y, 95% CI 0.02 to 0.39; <a href="#CD009878-fig-0003">Figure 3</a>); no heterogeneity was apparent. The different molecules used (mometasone, ciclesonide and fluticasone) did not seem to influence the magnitude of effect: χ<sup>2</sup> = 2.19; df = 2; P value 0.33; <a href="./references#CD009878-fig-0006" title="">Analysis 1.2</a>; <a href="#CD009878-fig-0004">Figure 4</a>). Data from <a href="./references#CD009878-bbs2-0027" title="SkonerDP , MeltzerEO , MilgromHA , StryszakP , TeperA , StaudingerH . Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo‐controlled trial in children 4‐9 years old with mild persistent asthma. Journal of Asthma2011;48(8):848‐59. ">Skoner 2011</a> weighed 10% in the primary outcome analysis. In <a href="./references#CD009878-bbs2-0027" title="SkonerDP , MeltzerEO , MilgromHA , StryszakP , TeperA , StaudingerH . Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo‐controlled trial in children 4‐9 years old with mild persistent asthma. Journal of Asthma2011;48(8):848‐59. ">Skoner 2011</a>, growth velocity was analysed using two different statistical models: a longitudinal random slope (LRS) model and an individual regression (IR) model; results from both of these methods were reported. The IR model resulted in poor estimates of growth rate with lower precision, as admitted by the study authors, and led to a different confidence interval around the pooled results. In contrast, the LRS model provided more robust growth rates. Consequently, we chose the data derived using the best (LRS) model, which led to a significant group difference in the primary outcome, recognising that use of the IR model would have led to a group difference approaching, but not reaching, statistical significance. </p> <div class="figure" id="CD009878-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Inhaled corticosteroids dose‐response effect, outcome: 1.1 Growth velocity (cm/y) by stadiometry from 0‐12 months." data-id="CD009878-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Inhaled corticosteroids dose‐response effect, outcome: 1.1 Growth velocity (cm/y) by stadiometry from 0‐12 months. </p> </div> </div> </div> <div class="figure" id="CD009878-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Inhaled corticosteroids dose‐response effect, outcome: 1.2 Subgroup analysis on the ICS molecules: growth velocity by stadiometry from 0‐12 months." data-id="CD009878-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Inhaled corticosteroids dose‐response effect, outcome: 1.2 Subgroup analysis on the ICS molecules: growth velocity by stadiometry from 0‐12 months. </p> </div> </div> </div> <p>We could not perform subgroup analysis on age, severity and ICS dose, as all trials contributing data to the primary outcome had similar characteristics in that they enrolled prepubertal children with mild or unknown severity of airway obstruction, used similarly low ICS doses and did not report or failed to specify the use of co‐interventions. Of note, in all four comparisons contributing data, the ICS dose difference between the two groups was less than or equal to 150 μg of HFA‐beclomethasone. </p> <p>As all trials contributing data to the primary outcome were published in full text with high methodological quality and were sponsored by the pharmaceutical industry, we could not perform sensitivity analyses to assess bias due to publication status, poor methodology or funding status. As the adherence rate for ICS was seldom or incompletely reported, sensitivity analysis was not performed on this criterion. </p> <p>No statistically significant group differences in linear growth (standardised in cm/y) were seen over the first three months (six comparisons; N = 1114 children; MD ‐0.12, 95% CI ‐0.51 to 0.27; <a href="./references#CD009878-fig-0007" title="">Analysis 1.3</a>) and no heterogeneity was apparent. Only two comparisons from the same trial provided data on growth velocity from zero to six months (<a href="./references#CD009878-fig-0008" title="">Analysis 1.4</a>) and from three to six months (<a href="./references#CD009878-fig-0009" title="">Analysis 1.5</a>); in both cases, a statistically significant group difference was not reported. </p> </section> </section> <section id="CD009878-sec-0072"> <h4 class="title">Secondary outcomes</h4> <section id="CD009878-sec-0073"> <h5 class="title">Change in growth velocity (cm/y)</h5> <p>Only one trial reported change in growth velocity from zero to 12 months with no statistically significant group difference (one comparison; N = 181 children; MD 0.06 cm/y, 95% CI ‐0.43 to 0.55; <a href="./references#CD009878-fig-0010" title="">Analysis 1.6</a>). </p> </section> <section id="CD009878-sec-0074"> <h5 class="title">Change in height (cm)</h5> <p>This outcome reflects the net change between final and initial height, without linear regression or adjustment for important co‐variates such as age, sex, puberty and baseline height. A statistically significant group difference was noted in the change in height from zero to three months in favour of the higher ICS dose (nine comparisons; N = 944 children; MD ‐0.15 cm, 95% CI ‐0.28 to ‐0.02; <a href="./references#CD009878-fig-0011" title="">Analysis 1.7</a>); children were described as having mild to moderate to severe asthma, and the ICS used were cicleconide, budesonide and fluticasone. However, the group difference was not statistically significant over longer or subsequent periods, that is, from zero to six months (three comparisons; N = 211 children; MD ‐0.03, 95% CI ‐0.33 to 0.27) (<a href="./references#CD009878-fig-0012" title="">Analysis 1.8</a>), from three to six months (two comparisons; N = 58 children; MD ‐0.01, 95% CI 0.74 to 0.71) (<a href="./references#CD009878-fig-0013" title="">Analysis 1.9</a>) and from zero to 12 months (four comparisons; N = 548 children; MD 0.25, 95% CI ‐0.04 to 0.54; <a href="./references#CD009878-fig-0014" title="">Analysis 1.10</a>). </p> </section> <section id="CD009878-sec-0075"> <h5 class="title">Change in standard deviation score (SDS) (height)</h5> <p>No statistically significant group difference in change in SDS (height) from zero to 12 months was reported (three comparisons; N = 328 children; MD 0.08, 95% CI ‐0.03 to 0.20; <a href="./references#CD009878-fig-0015" title="">Analysis 1.11</a>). </p> </section> <section id="CD009878-sec-0076"> <h5 class="title">Change in weight (kg)</h5> <p>No significant group difference in change in weight was seen from zero to three months (<a href="./references#CD009878-fig-0016" title="">Analysis 1.12</a>), from zero to six months (<a href="./references#CD009878-fig-0017" title="">Analysis 1.13</a>) and from zero to 12 months (<a href="./references#CD009878-fig-0018" title="">Analysis 1.14</a>). </p> </section> <section id="CD009878-sec-0077"> <h5 class="title">Change in body mass index (BMI) (kg/m<sup>2</sup>) </h5> <p>No significant group difference in change in BMI was noted from zero to six months (<a href="./references#CD009878-fig-0019" title="">Analysis 1.15</a>) or from zero to 12 months (<a href="./references#CD009878-fig-0020" title="">Analysis 1.16</a>). </p> </section> <section id="CD009878-sec-0078"> <h5 class="title">Change in skeletal maturation</h5> <p>Only one trial reported change in skeletal maturation, with a statistically significant group difference from zero to 12 months in favour of a lower ICS dose (one comparison; N = 181 children; MD 0.18, 95% CI 0.02 to 0.34; <a href="./references#CD009878-fig-0021" title="">Analysis 1.17</a>). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009878-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009878-sec-0079"></div> <p>This meta‐analysis aggregated data from 10 paediatric trials, providing 17 comparisons, as several studies tested more than two different doses of ICS or provided additional data subgrouped by age. In the four trials reporting the main outcome, a statistically significant group difference was seen in linear growth velocity measured by stadiometry over 12 months in prepubertal school‐aged children treated with low doses (i.e. 50 to 100 μg) versus low to medium doses (i.e. 200 μg of fluticasone, mometasone and ciclesonide). Of note, the statistically significant group difference was observed despite the small ICS dose difference between compared groups, varying between 100 and 150 μg/d (although most vary by 100 μg/d) of HFA‐propelled beclomethasone or equivalent in the four studies pooled. Of interest, a change in height between zero and three months showed a significant decrease of 0.15 cm in the opposite direction, that is, in disfavour of a lower ICS dose, underlying the impact of neglecting important co‐variates influencing growth (e.g. sex). This also raised the possibility of a beneficial effect of rapidly achieving asthma control (although this was not measured) and the impact of the timing of measurement of effect size, as this unadjusted group difference was not observed over subsequent and longer time periods. No statistically significant change from baseline in linear growth velocity, weight and body mass index was noted over zero to 12 months of ICS therapy in children. Our findings suggest a clear, yet small, dose‐dependent effect on growth when ICS are used at 200 μg/d or less—the cutoff for low to medium doses of ICS in children. </p> <p>The main outcome, growth velocity, that is, the pattern of growth measured repeatedly over time and adjusted for relevant co‐variates (in all individual trials but one (<a href="./references#CD009878-bbs2-0001" title="AllenDB , BronskyEA , LaForceCF , NathanRA , TinkelmanD , VandewalkerML , et al. Growth in asthmatic children treated with fluticasone propionate. Journal of Pediatrics1998;132(3 I):472‐7. ">Allen 1998</a>)), was measured in prepubertal school‐aged children (&lt; 12 years) treated with fluticasone propionate, ciclesonide and mometasone for 52 weeks. Of the 10 trials contributing data, only three trials (four comparisons) contributed data to the primary outcome (i.e. growth velocity (cm/y)) from zero to 12 months; all performed repeated height measurements using a stadiometer, were funded by pharmaceutical companies and were of high methodological quality. Trials used either a dry powder inhaler or a metered‐dose inhaler with spacer to deliver these three molecules with lower systemic bioavailability than budesonide and beclomethasone. Because of trial homogeneity, it was not possible to explore a possible modifier effect of age, severity of airway obstruction, asthma control, use of co‐interventions and ICS dose difference on growth velocity. Indeed, trials contributing data to this outcome predominantly compared low ICS doses versus low to medium doses, with a dose difference of 100 to 150 μg/d of HFA‐beclomethasone equivalent (<a href="./references#CD009878-bbs2-0110" title="Global Initiative for Asthma(GINA) . From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2014. http://www.ginasthma.org/local/uploads/files/GINA_Report_2014.pdf2014. ">GINA 2014</a>); higher doses of ICS theoretically offer greater potential for growth suppression (<a href="./references#CD009878-bbs2-0120" title="Expert Panel Report 2007. Guidelines for the Diagnosis and Management of Asthma [National Heart, Lung and Blood Institute, National Institute of Health]. www.nhlbi.nih.gov.clinical practice guidelines (accessed 10 December 2012). ">NHLBI Expert Panel Report 2012</a>). </p> <p>No effect of the choice of molecules within those tested was apparent. Indeed, several placebo‐controlled trials and Cochrane reviews have documented molecule dependency of growth suppression of ICS. Zhang and colleagues (<a href="./references#CD009878-bbs2-0138" title="ZhangL , AxelssonI , PrietschSOM . Inhaled corticosteroids in children with persistent asthma: effects on growth. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD009471] ">Zhang 2011</a>) are evaluating the growth‐suppressive effect of several ICS molecules compared with placebo, reporting minimal and less effect of fluticasone, mometasone and ciclesonide compared with budesonide and beclomethasone. Trials aggregated in this latter review had independently documented a growth‐suppressive effect at equivalent ICS doses of between 1.1 and 1.2 cm/y (<a href="./references#CD009878-bbs2-0102" title="SzeflerS , WeissS , TonasciaJ . Long‐term effects of budesonide or nedocromil in children with asthma. The New England Journal of Medecine2000;343:1054‐63. ">CAMP Research Group 2000</a>; <a href="./references#CD009878-bbs2-0103" title="KellyHW , SternbergAL , LescherR , FuhlbriggeAL , WilliamsP , ZeigerRS . Effect of inhaled glucocorticoids in childhood on adult height. The New England Journal of Medecine2012;367:904‐12. ">CAMP Research Group 2012</a>) with budesonide, 0.7 cm/y with mometasone (<a href="./references#CD009878-bbs2-0130" title="SkonerDP , MeltzerEO , MilgromH , StryszakP , TeperA , StaudingerH . Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo‐controlled trial in children 4‐9 years old with mild persistent asthma. The Journal of Asthma2011;48:848‐59. ">Skonner 2011</a>), a non‐significant group difference of 0.43 cm/y with fluticasone (<a href="./references#CD009878-bbs2-0127" title="SharekPJ , BergmanDA . The effect of inhaled steroids on the linear growth of children with asthma: a meta‐analysis. Pediatrics2000;106:e8. ">Sharek 2000b</a>) and none with ciclesonide (<a href="./references#CD009878-bbs2-0026" title="SkonerDP , MasperoJ , BanerjiD . Assessment of the long‐term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics2008;121(1):e1‐14. ">Skoner 2008</a>) in prepubertal school‐aged children, suggesting molecule dependence of the impact of ICS on growth. This finding is consistent with that of a previous Cochrane systematic review (<a href="./references#CD009878-bbs2-0126" title="SharekPJ , BergmanD , FrancineD . Beclomethasone for asthma in children: effects on linear growth. Cochrane Database of Systematic Reviews2000, Issue 2. [DOI: 10.1002/14651858.CD001282] ">Sharek 2000a</a>), which had produced solid evidence supporting the growth suppression of 400 μg of inhaled CFC‐propelled beclomethasone (equivalent to 200 HFA‐BDP) estimated at 1.54 cm/y over seven to 12 months in children with mild to moderate asthma. Current findings provide a clear indication that the use of ICS molecules believed to have no or little suppressive effect does have a minor, yet statistically significant, effect on growth when used at the lowest cutoff of the medium dosage compared with a lower dose. </p> <p>In this review, the observed group difference of 0.2 cm in growth velocity over the first year of treatment (with an upper confidence interval limit of 0.4 cm/y), associated with an ICS dose higher by 100 to 150 μg, represents less than half the observed effect with similar doses compared with placebo (<a href="./references#CD009878-bbs2-0102" title="SzeflerS , WeissS , TonasciaJ . Long‐term effects of budesonide or nedocromil in children with asthma. The New England Journal of Medecine2000;343:1054‐63. ">CAMP Research Group 2000</a>; <a href="./references#CD009878-bbs2-0126" title="SharekPJ , BergmanD , FrancineD . Beclomethasone for asthma in children: effects on linear growth. Cochrane Database of Systematic Reviews2000, Issue 2. [DOI: 10.1002/14651858.CD001282] ">Sharek 2000a</a>; <a href="./references#CD009878-bbs2-0127" title="SharekPJ , BergmanDA . The effect of inhaled steroids on the linear growth of children with asthma: a meta‐analysis. Pediatrics2000;106:e8. ">Sharek 2000b</a>; <a href="./references#CD009878-bbs2-0130" title="SkonerDP , MeltzerEO , MilgromH , StryszakP , TeperA , StaudingerH . Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo‐controlled trial in children 4‐9 years old with mild persistent asthma. The Journal of Asthma2011;48:848‐59. ">Skonner 2011</a>; <a href="./references#CD009878-bbs2-0103" title="KellyHW , SternbergAL , LescherR , FuhlbriggeAL , WilliamsP , ZeigerRS . Effect of inhaled glucocorticoids in childhood on adult height. The New England Journal of Medecine2012;367:904‐12. ">CAMP Research Group 2012</a>). It is consistent with a very small dose‐response effect and arguably is impossible to detect on a standard growth curve. One must recognise that the small observed group difference with the use of most recent molecules (fluticasone, mometasone and ciclesonide) might be much higher with a higher ICS dose and/or with older molecules (budesonide and beclomethasone), which have well‐documented growth‐suppressing effects. </p> <p>The two included trials (<a href="./references#CD009878-bbs2-0023" title="ShapiroG , BronskyEA , LaForceCF , MendelsonL , PearlmanD , SchwartzRH . Dose‐related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics1998;132(6):976‐82. ">Shapiro 1998 b</a>; <a href="./references#CD009878-bbs2-0032" title="VerberneAA , FrostC , DuivermanEJ , GrolMH , KerrebijnKF . Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. American Journal of Respiratory and Critical Care Medicine1998;158(1):213‐9. ">Verberne 1998</a>) that compared low doses versus higher doses of ICS (800 HFA‐BDP equivalent) contributed between 3% and 30% of the weight in only a few outcomes (1.7, 1.8, 1.10, 1.11 and 1.12), such that we cannot adequately explore the possibility of a differential effect on growth of a high versus low ICS dose. Although poorly controlled asthma may delay growth in children (<a href="./references#CD009878-bbs2-0120" title="Expert Panel Report 2007. Guidelines for the Diagnosis and Management of Asthma [National Heart, Lung and Blood Institute, National Institute of Health]. www.nhlbi.nih.gov.clinical practice guidelines (accessed 10 December 2012). ">NHLBI Expert Panel Report 2012</a>), evidence to support this statement is weak. Yet we cannot rule out the possibility of a growth‐suppressive effect of poorly controlled asthma in children receiving a lower ICS dose, which could counterbalance the growth suppression associated with a higher ICS dose. If disease‐associated growth suppression was indeed possible, even in children with mild to moderate asthma, the design of this review is adequate, as we are interested in the net growth‐suppressive effect of ICS therapy in children with asthma. In the absence of a placebo‐controlled group, we cannot rule out the unlikely hypothesis that most growth retardation may occur at a very low dose of ICS therapy, which could explain the clinically small group difference between different ICS doses. The systemic availability of ICS is directly related to cortisol suppression and growth suppression, especially in children. The particle size of the drug molecule and use of different devices influence systemic availabilities (<a href="./references#CD009878-bbs2-0117" title="MartinRJ , SzeflerSJ , ChinchilliVM , KraftM , DolovichM , BousheyHA , et al. Systemic effect comparisons of six inhaled corticosteroid preparations. American Journal of Respiratory and Critical Care Medicine2002;165:1377‐83. ">Martin 2002</a>; <a href="./references#CD009878-bbs2-0092" title="AgertoftL , LaulundLW , HarrisonLI , PedersenS . Influence of particle size on lung deposition and pharmacokinetics of beclomethasone dipropionatein children. Pediatric Pulmonology2003;35:192‐9. ">Agertoft 2003</a>; <a href="./references#CD009878-bbs2-0093" title="AgertoftL , PedersenS . Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children. American Journal of Respiratory and Critical Care Medicine2003;168:779‐82. ">Agertoft 2003a</a>). The third of this series of Cochrane reviews will examine the effects of different devices on the growth of asthmatic children. </p> <p>As trials contributing data lasted a maximum of one year, the long‐term impact of different ICS doses on growth velocity beyond one year could not be explored. Our observations complement those of several placebo‐controlled studies, suggesting that the growth‐suppressive effect of ICS is non‐cumulative (<a href="./references#CD009878-bbs2-0128" title="Simons FER and Canadian Beclomethasone Dipropionate‐Salmeterol Xinafoate Study Group. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. The New England Journal of Medicine1997;337:1659‐65. ">Simons 1997</a>) and may be associated with partial catch‐up (<a href="./references#CD009878-bbs2-0111" title="GuilbertTW , MorganWJ , ZeigerRS , MaugerDT , BoehmerSJ , SzeflerSJ . Long‐term inhaled corticosteroids in preschool children at high risk for asthma. The New England Journal of Medecine2006;354:1985‐97. ">Guilbert 2006a</a>), as a growth deficit may be sustained until adulthood (<a href="./references#CD009878-bbs2-0103" title="KellyHW , SternbergAL , LescherR , FuhlbriggeAL , WilliamsP , ZeigerRS . Effect of inhaled glucocorticoids in childhood on adult height. The New England Journal of Medecine2012;367:904‐12. ">CAMP Research Group 2012</a>). </p> <p>Of interest, the significant group difference in the 'unadjusted' change in height between zero and three months suggests a favourable effect of ICS on growth in the first three months of use, perhaps via improved asthma control. Of note, 54% of the weight of this analysis is derived from a single trial testing various doses of ciclesonide (with a molecule with no demonstrated suppressive effect on growth) in children with partially or poorly controlled asthma (<a href="./references#CD009878-bbs2-0020" title="PedersenS , PotterP , DachevS , BoshevaM , KaczmarekJ , SpringerE , et al. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the rainbow study. Respiratory Medicine2010;104(11):1618‐28. ">Pedersen 2010</a>; <a href="./references#CD009878-bbs2-0021" title="PedersenS , PotterP , DachevS , BoshevaM , KaczmarekJ , SpringerE , et al. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the rainbow study. Respiratory Medicine2010;104(11):1618‐28. ">Pedersen 2010 b</a>). However, this hypothesis is weakened by the absence of any statistically significant effect observed between three and six months and between zero and six months, suggesting a transient beneficial effect on growth, insufficient power or a type 1 error, that is, falsely identifying a significant effect when one does not exist. Of importance, the absence of adjustment for important confounders decreases the quality of the evidence derived from this outcome. </p> <p>No statistically significant group difference was observed in other aggregated parameters, namely, change from baseline in weight, change in SD scores (height) and body mass index. A significant group difference in skeletal maturation of a quarter of a year was observed, in disfavour of a higher dose (200 μg/d), with an ICS group difference of 100 μg/d of HFA‐propelled beclomethasone or equivalent (<a href="./references#CD009878-bbs2-0001" title="AllenDB , BronskyEA , LaForceCF , NathanRA , TinkelmanD , VandewalkerML , et al. Growth in asthmatic children treated with fluticasone propionate. Journal of Pediatrics1998;132(3 I):472‐7. ">Allen 1998</a>). Given that children with asthma may have delayed puberty (boys more than girls) (<a href="./references#CD009878-bbs2-0120" title="Expert Panel Report 2007. Guidelines for the Diagnosis and Management of Asthma [National Heart, Lung and Blood Institute, National Institute of Health]. www.nhlbi.nih.gov.clinical practice guidelines (accessed 10 December 2012). ">NHLBI Expert Panel Report 2012</a>), whether the delayed maturation is due to poorer asthma control or is associated with greater use of ICS, or both, remains to be determined. Nevertheless, the observation on skeletal maturation, derived from a single study, requires replication. </p> <section id="CD009878-sec-0080"> <h3 class="title" id="CD009878-sec-0080">Summary of main results</h3> <p>Three industry‐funded trials with high methodological quality (resulting in four dose comparisons) contributed data to the main outcome, that is, growth velocity; they measured 728 school‐aged children with mild to moderate asthma and used one of three molecules (fluticasone, ciclesonide or mometasone) to compare groups with a dose difference ≤ 150 μg over 52 weeks. A significant group difference in linear growth was observed over 12 months, indicating lower growth velocity in the higher ICS dose group (mean difference 0.20 cm/y, 95% CI 0.02 to 0.39); no heterogeneity was apparent. Within aggregated trials, the different ICS molecules did not significantly influence the magnitude of effect (P value 0.33), but no trial contributing data to the main outcome used budesonide or beclomethasone. </p> </section> <section id="CD009878-sec-0081"> <h3 class="title" id="CD009878-sec-0081">Overall completeness and applicability of evidence</h3> <p>This review summarises the best evidence available until March 2014 as derived from 10 trials (resulting in 17 comparisons) aggregating 3394 children with mild to moderate persistent asthma. Most trials were of high methodological quality. The systematic search, which identified eligible trials from published and unpublished reports (406 citations) and used selection and data extraction by two independent review authors, minimised the risk of inclusion bias. The outstanding collaboration of study authors and pharmaceutical groups from six trials (resulting in eight comparisons) allowed us to obtain additional unpublished data and to confirm methodological quality, both of which strengthened the meta‐analysis. Because of the paucity of trials reporting these data, four of 15 secondary outcomes could not be aggregated. The long‐term impact of low versus high ICS dose on growth velocity, weight, skeletal maturation and body mass index in children using the same and older ICS molecules beyond one year of follow‐up remains to be addressed. Sensitivity analysis could not be performed, as all trials were at low risk of bias, the adherence rate of ICS was seldom reported and all included trials contributing data to the main outcome were funded by the pharmaceutical industry and published as full text. In real life, most physicians would adjust downward or upward the dose of ICS needed to maintain control; we acknowledge that the artificially fixed dose for one to four years would overestimate growth suppression when compared with the recommended practice of decreasing to the minimal effective dose, yet this is a basic requirement of FDA guidelines for assessment of the effects of ICS on growth. Our study results support the Global Initiative for Asthma (GINA) guideline recommendations and serve as a reminder that physicians should strive to adjust to the minimal effective ICS dose, irrespective of the ICS molecule selected. </p> </section> <section id="CD009878-sec-0082"> <h3 class="title" id="CD009878-sec-0082">Quality of the evidence</h3> <p>The quality of evidence of growth velocity was high, but for outcomes reflecting change in height from baseline between treatment groups, the quality of evidence was downgraded to moderate owing to possible prognostic imbalance from the use of unadjusted data in the analysis. We downgraded the quality of evidence to low for BMI, weight and skeletal maturation due to imprecision (See <a href="./full#CD009878-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD009878-sec-0083"> <h3 class="title" id="CD009878-sec-0083">Potential biases in the review process</h3> <p>Some bias may or may not have affected the magnitude of effect. All trials contributing data to the main outcome used a stadiometer to measure growth; this enhances the internal validity of the findings. As each trial compared different doses using the same device, we could not explore the possibility that the magnitude of effect may be associated with the choice of inhalation device; however a linked Cochrane review is addressing this point (<a href="./references#CD009878-bbs2-0138" title="ZhangL , AxelssonI , PrietschSOM . Inhaled corticosteroids in children with persistent asthma: effects on growth. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD009471] ">Zhang 2011</a>). </p> </section> <section id="CD009878-sec-0084"> <h3 class="title" id="CD009878-sec-0084">Agreements and disagreements with other studies or reviews</h3> <p>To our knowledge, no prior systematic review has evaluated the relationship between dose of ICS and risk of growth impairment in children with persistent asthma. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009878-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Flow diagram of screening of trials." data-id="CD009878-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Flow diagram of screening of trials.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/full#CD009878-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009878-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/full#CD009878-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Inhaled corticosteroids dose‐response effect, outcome: 1.1 Growth velocity (cm/y) by stadiometry from 0‐12 months." data-id="CD009878-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Inhaled corticosteroids dose‐response effect, outcome: 1.1 Growth velocity (cm/y) by stadiometry from 0‐12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/full#CD009878-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Inhaled corticosteroids dose‐response effect, outcome: 1.2 Subgroup analysis on the ICS molecules: growth velocity by stadiometry from 0‐12 months." data-id="CD009878-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Inhaled corticosteroids dose‐response effect, outcome: 1.2 Subgroup analysis on the ICS molecules: growth velocity by stadiometry from 0‐12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/full#CD009878-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 1 Growth velocity (cm/y) by stadiometry from 0‐12 months." data-id="CD009878-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 1 Growth velocity (cm/y) by stadiometry from 0‐12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#CD009878-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 2 Subgroup analysis on the ICS molecules: growth velocity by stadiometry from 0‐12 months." data-id="CD009878-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 2 Subgroup analysis on the ICS molecules: growth velocity by stadiometry from 0‐12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#CD009878-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 3 Growth velocity (cm/y) by stadiometry from 0‐3 months." data-id="CD009878-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 3 Growth velocity (cm/y) by stadiometry from 0‐3 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#CD009878-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 4 Growth velocity (cm/y) by stadiometry from 0‐6 months." data-id="CD009878-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 4 Growth velocity (cm/y) by stadiometry from 0‐6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#CD009878-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 5 Growth velocity (cm/y) by stadiometry from 3‐6 months." data-id="CD009878-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 5 Growth velocity (cm/y) by stadiometry from 3‐6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#CD009878-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 6 Change in growth velocity (cm/y) by stadiometry from 0‐12 months." data-id="CD009878-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 6 Change in growth velocity (cm/y) by stadiometry from 0‐12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#CD009878-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 7 Change in height (cm) by stadiometry from 0‐3 months." data-id="CD009878-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 7 Change in height (cm) by stadiometry from 0‐3 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#CD009878-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 8 Change in height (cm) by stadiometry from 0‐6 months." data-id="CD009878-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 8 Change in height (cm) by stadiometry from 0‐6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#CD009878-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 9 Change in height (cm) by stadiometry from 3‐6 months." data-id="CD009878-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 9 Change in height (cm) by stadiometry from 3‐6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#CD009878-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 10 Change in height (cm) by stadiometry from 0‐12 months." data-id="CD009878-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 10 Change in height (cm) by stadiometry from 0‐12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#CD009878-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 11 Change in SD scores (height) from 0‐12 months." data-id="CD009878-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 11 Change in SD scores (height) from 0‐12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#CD009878-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 12 Change in weight (kg) from 0‐3 months." data-id="CD009878-fig-0016" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 12 Change in weight (kg) from 0‐3 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#CD009878-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 13 Change in weight (kg) from 0‐6 months." data-id="CD009878-fig-0017" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 13 Change in weight (kg) from 0‐6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#CD009878-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 14 Change in weight (kg) from 0‐12 months." data-id="CD009878-fig-0018" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 14 Change in weight (kg) from 0‐12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#CD009878-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 15 Change in BMI (kg/m2) from 0‐6 months." data-id="CD009878-fig-0019" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 15 Change in BMI (kg/m<sup>2</sup>) from 0‐6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#CD009878-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 16 Change in BMI (kg/m2) from 0‐12 months." data-id="CD009878-fig-0020" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 16 Change in BMI (kg/m<sup>2</sup>) from 0‐12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#CD009878-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009878-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/urn:x-wiley:14651858:media:CD009878:CD009878-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_t/tCD009878-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 17 Change in skeletal maturation (years) from 0‐12 months." data-id="CD009878-fig-0021" src="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Inhaled corticosteroids dose‐response effect, Outcome 17 Change in skeletal maturation (years) from 0‐12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#CD009878-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/media/CDSR/CD009878/image_n/nCD009878-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009878-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Inhaled corticosteroids dose‐response effect</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Inhaled corticosteroids dose‐response effect</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> children with persistent asthma<br/> <b>Settings:</b> outpatients<br/> <b>Intervention:</b> lower‐dose inhaled corticosteroids </p> <p><b>Control:</b> higher‐dose ICS </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control group (higher‐dose ICS)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Intervention group (lower‐dose ICS)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Growth velocity over 12 months (cm/y)</b> <br/> (higher is better) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean growth velocity was 5.74 cm/y (range, 5.6 to 5.88)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Corresponding growth velocity on lower‐dose ICS was 0.2 cm/y higher: mean 5.94 cm/y (95% CI 5.76 to 6.13) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.20</b> (0.02 to 0.39) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>728<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Skoner 2011 data analysed using LRS model were used</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in height over 3 months (cm)</b> </p> <p>(higher is better)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Unadjusted mean change in height over 3 months was 1.34 cm (range, 0.9 to 1.8 cm)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Corresponding unadjusted change in height on lower‐dose ICS was 0.15 cm lower: mean 1.19 cm (95% CI 1.06 to 1.32) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD ‐0.15</b> (‐0.28 to ‐0.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>944<br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data analysis was unadjusted for confounders</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in height over 12 months (cm)</b> <br/> (higher is better) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Unadjusted mean change in height over a year was 4.56 cm (range, 3.6 to 5.73 cm)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Corresponding unadjusted change in height on lower‐dose ICS was 0.25 cm higher; mean 4.81 cm (95% CI 4.52 to 5.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.25</b> (‐0.04 to 0.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>548<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data analysis was unadjusted for confounders</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in SD scores over 12 months (height)</b> </p> <p>(low change is better)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Unadjusted mean change in SD score was ‐0.18 (range, ‐0.01 to ‐0.27)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Corresponding mean unadjusted change on lower‐dose ICS was 0.08 less; mean ‐0.10 (95% CI ‐0.21 to 0.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.08</b> (‐0.03 to 0.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>328<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data analysis was unadjusted for confounders</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in weight over 12 months (kg)</b> <br/> (higher is better) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean change in weight was 3.4 kg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Corresponding mean change in weight on lower‐dose ICS was 0.3 kg lower: mean 3.1 (95% CI 2.58 to 3.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD</b> ‐0.30 (‐0.82 to 0.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>408<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Based on only 1 trial</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in BMI over 12 months (kg/m<sup>2</sup>)</b> <br/> (higher is better) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean change in BMI was 0.7 kg/m<sup>2</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Corresponding mean change in BMI on lower‐dose ICS was 0.2 kg/m<sup>2</sup> less: mean 0.5 (95% CI 0.21 to 0.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD</b> ‐0.20 (‐0.49 to 0.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>408<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Based on only 1 trial</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in skeletal maturation over 12 months (years)</b> </p> <p>(higher is better)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean change in skeletal maturation was 0.95 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Corresponding mean change in skeletal maturation on lower‐dose ICS was 0.18 years more; mean 1.13 (95% CI 0.97 to 1.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD</b> 0.18 (0.02 to 0.34) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>181<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Based on only 1 trial</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> was the weighted mean control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Data analysis was unadjusted for confounders. </p> <p><sup>2</sup>Based on only 1 trial. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Inhaled corticosteroids dose‐response effect</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/full#CD009878-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009878-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">FDA study design</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Run‐in period ≥ 16 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Tx period ≥ 48 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Follow‐up period (to access catch‐up period)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Follow‐up period ≥ 8 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Recommended age (male: 3‐10.5 years; female: 3‐9.5 years, prepuberty (Tanner 1))</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mild asthma severity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No use of spacers</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo or active control group with no growth‐suppressing effect</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Allen 1998</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (2 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes<br/> (52 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Brand 2011</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (2‐4 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (24 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Partially (2‐6 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes (placebo or montelukast if control was insufficient)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pedersen 2010</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (2‐4 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (12 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes (6‐11 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Shapiro 1998</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> <p>(2 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (12 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No (6‐18 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Skoner 2008</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes<br/> (6 months) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes<br/> (52 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes<br/> (8 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes (5‐8 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Skoner 2011</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (1‐2 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes<br/> (52 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes<br/> (12 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sorkness 2007</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (2‐4 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes<br/> (48 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No (6‐14 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No (mild to moderate)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes (montelukast)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Vaessen‐Verberne 2010</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (6 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (26 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No (6‐16 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No (moderate)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Verbern 1998</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (6 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes<br/> (54 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No (6‐16 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes (salmeterol)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Wasserman 2006</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (2‐4 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No<br/> (12 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Partially (24‐47 months)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>FDA = US Food and Drug Administration; NR = not reported.</p> <p>All studies were randomised, placebo‐controlled, double‐blind, parallel‐group trials.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">FDA study design</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/full#CD009878-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009878-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">FDA statistical methods</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intention‐to‐treat analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Exclusion of pubescent children in analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Low and balanced withdrawals or missing data or patient dropouts</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Data presented as linear regression model but not change in height</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Baseline height, age, sex used as confounders in analysis model</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Catch‐up growth analysed with a linear regression model</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No nasal steroid during the study</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Allen 1998</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Brand 2011</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pedersen 2010</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No (dropout in placebo: 24% vs active treatment: 16%‐18%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Shapiro 1998</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Skoner 2008</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Skoner 2011</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sorkness 2007</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Vaessen‐Verberne 2010</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Verbern 1998</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Wasserman 2006</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">FDA statistical methods</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/full#CD009878-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009878-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">FDA possible sources of bias</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Use of stadiometer</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Height evaluation by same trained blinded examiner</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Height evaluation at the same time of the visit day</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Repeated (≥ 3) measurements during the study period</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Record of compliance</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Allen 1998</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Brand 2011</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pedersen 2010</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Shapiro 1998</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Skoner 2008</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Skoner 2011</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sorkness 2007</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Vaessen‐Verberne 2010</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Verbern 1998</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Wasserman 2006</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">FDA possible sources of bias</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/full#CD009878-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009878-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Inhaled corticosteroids dose‐response effect</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Growth velocity (cm/y) by stadiometry from 0‐12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>728</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.02, 0.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Subgroup analysis on the ICS molecules: growth velocity by stadiometry from 0‐12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>728</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.02, 0.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Mometasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.02, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Ciclesonide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>408</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐0.09, 0.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Fluticasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [‐0.16, 0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Growth velocity (cm/y) by stadiometry from 0‐3 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐0.51, 0.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Growth velocity (cm/y) by stadiometry from 0‐6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐2.40, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Growth velocity (cm/y) by stadiometry from 3‐6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐3.35, 3.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Change in growth velocity (cm/y) by stadiometry from 0‐12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Change in height (cm) by stadiometry from 0‐3 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>944</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐0.28, ‐0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Change in height (cm) by stadiometry from 0‐6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>211</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.27, 0.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Change in height (cm) by stadiometry from 3‐6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.74, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Change in height (cm) by stadiometry from 0‐12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>548</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [‐0.04, 0.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Change in SD scores (height) from 0‐12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>328</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐0.03, 0.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Change in weight (kg) from 0‐3 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>449</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [‐0.13, 0.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Change in weight (kg) from 0‐6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.24, 0.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Change in weight (kg) from 0‐12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Change in BMI (kg/m<sup>2</sup>) from 0‐6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐0.22, 0.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Change in BMI (kg/m<sup>2</sup>) from 0‐12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Change in skeletal maturation (years) from 0‐12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Inhaled corticosteroids dose‐response effect</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009878.pub2/references#CD009878-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009878.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD009878-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD009878-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009878-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009878-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD009878-note-0002">Bahasa Malaysia</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009878\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009878\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009878\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009878\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009878\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009878\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009878\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009878\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009878\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009878\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009878\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009878\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009878\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009878\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009878\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009878\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009878\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009878\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=JmNqPX1V&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009878.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009878.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009878.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009878.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009878.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716127528"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009878.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716127532"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009878.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d97e95ba2f409',t:'MTc0MDcxNjEyNy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 